# EDGAR Filing Document

**Accession Number:** 0001517767
**File Stem:** 0001517767-26-000039
**Filing Date:** 2026-5
**Character Count:** 172559
**Document Hash:** e0e29846e82be1ceb3f9a02af521fd41
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001517767-26-000039.hdr.sgml**: 20260519

**ACCESSION NUMBER**: 0001517767-26-000039

**CONFORMED SUBMISSION TYPE**: N-CSRS

**PUBLIC DOCUMENT COUNT**: 23

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260519

**DATE AS OF CHANGE**: 20260519

**EFFECTIVENESS DATE**: 20260519

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Carlyle Credit Income Fund
- **CENTRAL INDEX KEY:** 0001517767

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** N-CSRS
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22554
- **FILM NUMBER:** 26998482

**BUSINESS ADDRESS:**
- **STREET 1:** ONE VANDERBILT AVENUE
- **STREET 2:** SUITE 3400
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 212-813-4900

**MAIL ADDRESS:**
- **STREET 1:** ONE VANDERBILT AVENUE
- **STREET 2:** SUITE 3400
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Vertical Capital Income Fund
- **DATE OF NAME CHANGE:** 20110411

?xml version='1.0' encoding='ASCII'? ck0001517767-20260331

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM N-CSRS**

**CERTIFIED SHAREHOLDER REPORT OF REGISTERED**

**MANAGEMENT INVESTMENT COMPANIES**

**Investment Company Act File Number 811-22554**

## Carlyle Credit Income Fund
**(Exact Name of Registrant as Specified In Its Charter)**

**One Vanderbilt Avenue, Suite 3400**

**New York, New York 10017**

**(Address of principal executive offices) (Zip Code)**

**Joshua Lefkowitz, Esq.**

**Chief Legal Officer, Carlyle Credit Income Fund**

**One Vanderbilt Avenue, Suite 3400**

**New York, New York 10017**

**(Name and address of agent for service)**

**Registrant's telephone number, including area code: (212) 813-4900**

**Date of fiscal year end: September 30**

**Date of reporting period: March 31, 2026**

**<u>Item 1. Reports to Stockholders</u>**

The semi-annual report to stockholders for the six month period ended March 31, 2026 is filed herewith pursuant to Rule 30e -1

under the Investment Company Act of 1940.

![Carlyle-Logo-blue.jpg](ck0001517767-20260331_g1.jpg)

**CARLYLE CREDIT INCOME FUND**

**SEMI-ANNUAL REPORT** 

**MARCH 31, 2026**

**IMPORTANT INFORMATION**

**About Carlyle Credit Income Fund**

Carlyle Credit Income Fund is an externally managed closed-end fund focused on primarily investing in equity and

junior debt tranches of collateralized loan obligations ("CLOs"). The CLOs are collateralized by a portfolio consisting primarily

of U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors. With Carlyle

Global Credit Investment Management L.L.C. ("Carlyle" or "CGCIM") as its investment adviser, the Fund draws upon the

significant scale and resources of Carlyle and its affiliates as one of the world's largest CLO managers. For more information,

visit www.carlylecreditincomefund.com.

**Forward Looking Statements**

This report may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform

Act of 1995. Statements other than statements of historical facts included in this report may constitute forward-looking

statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. Actual

results may differ materially from those in the forward-looking statements as a result of a number of factors, including those

described in the Fund's filings with the SEC. The Fund undertakes no duty to update any forward-looking statement made

herein. All forward-looking statements speak only as of the date of this report.

**Table of Contents**

---

| | |
|:---|:---|
| **Section** | **Page** |
| Letter to Shareholders and Management's Discussion of Fund Performance | <u>[1](#i2ea0bd6f451241f4856787198a0981de_22)</u> |
| Summary of Certain Unaudited Portfolio Characteristics | <u>[3](#i2ea0bd6f451241f4856787198a0981de_52)</u> |
| Fees and Expenses | <u>[5](#i2ea0bd6f451241f4856787198a0981de_55)</u> |
| Statement of Assets and Liabilities | <u>[7](#i2ea0bd6f451241f4856787198a0981de_58)</u> |
| Schedule of Investments | <u>[8](#i2ea0bd6f451241f4856787198a0981de_61)</u> |
| Statement of Operations | <u>[11](#i2ea0bd6f451241f4856787198a0981de_67)</u> |
| Statements of Changes in Net Assets | <u>[12](#i2ea0bd6f451241f4856787198a0981de_70)</u> |
| Statement of Cash Flows | <u>[13](#i2ea0bd6f451241f4856787198a0981de_73)</u> |
| Financial Highlights | <u>[14](#i2ea0bd6f451241f4856787198a0981de_76)</u> |
| Notes to Financial Statements | <u>[16](#i2ea0bd6f451241f4856787198a0981de_79)</u> |
| Dividend Reinvestment Plan | <u>[35](#i2ea0bd6f451241f4856787198a0981de_130)</u> |
| Portfolio Proxy Voting Policies and Proxy Voting Record | <u>[36](#i2ea0bd6f451241f4856787198a0981de_139)</u> |
| Additional Information | <u>[37](#i2ea0bd6f451241f4856787198a0981de_142)</u> |

---

![](ck0001517767-20260331_g2.gif)

<sup>1</sup> Carlyle Internal Sources as of December 31, 2025

<sup>2</sup> Leveraged Commentary & Data ("LCD") as of March 31, 2026

<sup>3</sup> Bloomberg as of March 31, 2026

<sup>4</sup> Standard & Poor's Dow Jones Indices as of March 31, 2026

<sup>5</sup> LCD as of March 31, 2026

<sup>6</sup> Levfin Insights as of March 31, 2026

<sup>7</sup> LCD as of March 31, 2026

<sup>8</sup> Citi research as of March 31, 2026

<sup>9</sup> Wells Fargo Research as of March 31, 2026

<sup>10</sup> Citi research as of March 31, 2026

**Letter to Shareholders and Management's Discussion of Fund Performance**

**FUND REVIEW & DISCUSSION OF** 

**PERFORMANCE**

On May 19, 2026, Carlyle Credit Income Fund ("we,"

"us," "our," "CCIF" or the "Fund") (NYSE: CCIF)

announced via press release the financial results for the

second quarter ending March 31, 2026. Over the past six

months, the Fund has successfully implemented the

following:

• The Fund currently holds a diversified portfolio

consisting of 44 unique collateralized loan

obligation ("CLO") investments managed by 24

different collateral managers with exposure to

1,850 separate loans.

• The weighted average GAAP yield of the

portfolio is 11.06% as of March 31, 2026.

• The Fund completed 6 accretive CLO

refinancings and resets in the underlying portfolio

to either reduce the weighted average cost of debt

in the CLO or to extend the reinvestment period.

• CCIF is providing a 21.49% annualized dividend

based on the share price as of May 12, 2026.

• We refinanced $52 million 8.75% Series A Term

Preferred Shares with lower cost preferred shares

with a weighted average coupon of 7.33%.

◦ Issued $30 million of 7.375% Series D

Term Preferred Shares (NYSE: CCID)

◦ Completed a $17.5 million private

placement of 7.25% Series E Convertible

Preferred Shares

• We redeemed all $20 million 7.50% Series C

Convertible Preferred Shares

As of March 31, 2026, the NAV of the Fund is $3.34 per

share.

The Fund continues to hold one legacy real estate asset in

the portfolio that was inherited from the prior advisor of

the Fund. The fair market value of the loan is $2.2 million.

We believe Carlyle's 15 years of CLO investment

experience and its team of over 30+ credit investment

professionals across the U.S. and Europe provide

differentiated insights into the CLO market. Carlyle

remains one of the largest CLO managers globally with

approximately $50 billion in AUM and $3.4 billion in third

party managed CLO investments.<sup>1</sup>

**MARKET REVIEW**

Leveraged loans posted negative returns in Q1 2026 amid

shifting market sentiment driven by geopolitical volatility,

inflationary pressures, and uncertainty surrounding AI-

driven disruption. The LSTA U.S. Leveraged Loan Index

(the "LSTA Index") returned -0.6% for Q1 2026,

compared to -0.5% for high yield bonds and -4.3% for the

S&P 500.<sup>2,3,4</sup> The Index price ended the quarter at $94.63,

with only 14% of loans trading above par.<sup>5</sup> Market

conditions were characterized by increased dispersion

across sectors and issuers during the quarter.

Opportunistic loan repricing and refinancing activity was

elevated in January, with repricings totaling $105.8 billion,

but slowed materially over the remainder of Q1 2026,

reflecting increased market volatility and softer secondary

loan prices.<sup>6</sup> As a result, gross loan issuance totaled $223.8

billion in Q1 2026, representing a 33% decrease from Q1

2025.<sup>6</sup> However, the market saw a pickup in larger new

money transactions, including Electronic Arts, the largest

leverage buyout ever. These transactions were generally

met with strong investor demand, contributing to $51.0

billion of quarterly new money activity in the broadly

syndicated loan ("BSL") market, the highest level in four

years.<sup>7</sup>

The CLO market was active at the start of Q1 2026, with

strong issuance in January, before activity moderated over

the remainder of the quarter following increased market

volatility.<sup>8</sup> New issuance totaled $48.4 billion in the

quarter, up from $45.0 billion in Q1 2025, as managers

continued to access the primary market despite increased

volatility.<sup>8</sup> CLOs remained a key source of demand for

leveraged loans, helping to support primary issuance and

secondary market liquidity. Liability spreads widened

modestly across the capital stack, with AAA spreads

widening by approximately 5 bps quarter-over-quarter and

BB spreads at approximately 150 bps, contributing to a

moderation in refinancing and reset activity during the

quarter.<sup>9</sup> CLO resets and refinances totaled $31.8 billion

and $23.7 billion, respectively during the quarter, as

managers continued to evaluate opportunities to extend

reinvestment periods and optimize financing costs.<sup>10</sup>

![](ck0001517767-20260331_g3.gif)

<sup>11</sup> Carlyle Internal Sources as of December 31, 2025

<sup>12</sup> JPM Default Monitor as of March 31, 2026

<sup>13</sup> Creditflux as of March 31, 2026

<sup>14</sup> Carlyle Internal Sources as of March 31, 2026

Credit fundamentals across CLO portfolios remained

broadly stable. Using Carlyle's U.S. loan portfolio of over

550 borrowers as a proxy, more than 75% of borrowers

generated positive free cash flow.<sup>11</sup> Average borrower

EBITDA and revenue growth were 3.0% and 4.9%,

respectively, in Q4 2025.<sup>11</sup> The average Interest Coverage

Ratio ("ICR") remained healthy at approximately 3.8x,

reflecting continued focus on managing interest expense

and maintaining steady underlying cash flows.<sup>11</sup>

While fundamentals remain stable overall, pressure is

building at the margins among lower-quality credits. These

metrics provide important insight into the health of the

underlying collateral and continue to inform our bottom-up

CLO investment process.

As of March 31, 2026, the J.P. Morgan Leveraged Loan

Index default rate, including distressed exchanges ("DEs"),

was 3.04%, compared to a recent peak of 4.49% in

December 2024.<sup>12</sup> Carlyle continues to leverage the

insights of its dedicated Special Credits Group and 30+

credit analysts when evaluating loan borrowers in third-

party managed CLO portfolios. This is evidenced by a

CCIF portfolio default rate of approximately 1.18%,

inclusive of DEs, which remains meaningfully below the

broader market rate.

While extended reinvestment periods continue to support

CLO structures, wider liability spreads, weaker marks in

software loans, and softer loan prices contributed to

pressure on CLO equity cash-on-cash distributions and the

fair market value of CLO equity positions. Importantly,

recent performance in CLO equity reflects valuation and

technical factors rather than a deterioration in underlying

credit fundamentals, as portfolio credit metrics remained

broadly stable. Repricing activity moderated in February

and March following elevated levels in January and

throughout 2025, though its cumulative impact continues

to influence cash flows. These dynamics have been driven

in part by supply and demand imbalances in the loan

market, including periods of limited net issuance and

evolving investor demand. As a result, quarterly payments

for CLO equity declined modestly during the quarter.

**STRATEGY & OUTLOOK**

We remain confident in the resilience of our portfolio,

which is diversified across high-quality managers and

structured to navigate evolving market conditions. While

liability costs have increased and equity distributions have

moderated, we believe resilient credit fundamentals and

continued demand for floating rate assets will support CLO

performance over time. Recent performance has been

driven more by valuation and technical factors than

underlying credit deterioration, and we continue to see

opportunities emerging as market conditions evolve.

CLO equity remains positioned to benefit from improving

market dynamics, supported by transactions with extended

reinvestment periods. Primary market activity has

moderated from the elevated pace seen in 2025 and is

expected to remain more measured in the near term. Future

results will depend on managers' reinvestment discipline

and their ability to actively manage portfolios and mitigate

credit risk.

We continue to monitor the impact of market volatility and

have positioned CCIF's portfolio conservatively, with a

focus on experienced managers and portfolios

demonstrating strong par build and credit discipline. This

approach has resulted in a weighted average junior

overcollateralization cushion of 4.18%.

We continue to deploy capital selectively, focusing on

opportunities that offer compelling relative value across

both new and seasoned transactions. We leverage Carlyle's

in-house credit research team, part of one of the largest

U.S. CLO managers, to conduct detailed, bottom-up

analysis on each underlying loan, including software-

related exposures, with a focus on identifying and

assessing tail risks across portfolios.<sup>13</sup> We are increasingly

focused on the evolving implications of AI-driven

disruption across leveraged finance, particularly within

software companies; however, we believe these risks are

partially mitigated by the portfolio's overall diversification

and senior positioning. Our exposure remains highly

diversified across 1,850 underlying loans, with exposure to

any single loan representing less than 1% of the portfolio.<sup>14</sup>

In addition, our portfolios are predominantly comprised of

first-lien senior secured loans (over 97% of exposure),

where loan-to-value ratios are typically below 50%,

providing a meaningful cushion against potential

downside.<sup>14</sup> As such, we view current risks as less about

near-term operating deterioration and more related to

valuation pressure, potential moderation in growth, and

increased investment requirements for issuers to remain

competitive.

For CCIF, we remain focused on CLO equity positions

with clean underlying loan portfolios. We continue to

leverage Carlyle's 15-step CLO investment process and the

credit expertise of the broader Carlyle Liquid Credit

platform.

**SUMMARY OF CERTAIN UNAUDITED PORTFOLIO CHARACTERISTICS**

The information presented below is on a look-through basis to the collateralized loan obligation, or "CLO", equity and related

investments held by the Fund as of March 31, 2026, and reflects the aggregate underlying exposure of the Fund based on the

portfolios of those investments. The data is estimated, unaudited, and derived from CLO trustee reports received by the Fund as

of and for the six month period ended March 31, 2026 and from custody statements and/or other information received from

CLO collateral managers, or third party sources.

**Portfolio Investment Breakdown as of March 31, 2026**

(Excludes cash equivalents and other assets)

![Portfolio Investment Breakdown.jpg](ck0001517767-20260331_g4.jpg)

---

| | |
|:---|:---|
| **Summary of Underlying Portfolio** | **Summary of Underlying Portfolio** |
| Number of Unique Underlying Loan Obligors | 1423 |
| Number of Underlying Loans | 1850 |
| Aggregate Balance of Underlying Loans | $17.89 Billion |
| Average Individual Loan Obligor Exposure | 0.07% |
| Currency: USD Exposure | 100.00% |
| Aggregate Indirect Exposure to Senior Secured Loans | 97.18% |
| Weighted Average Junior OC Cushion | 4.18% |
| Weighted Average Market Price of Loan Collateral | 94.32 |
| Weighted Average Remaining CLO Reinvestment Period | 3.28 years |
| CCIF's Last 12 Month Default Rate including Distressed Exchanges of <br>Underlying Loans<br>| 1.18% |
| Loan Market Default Rate including Distressed Exchanges | 3.04% |

---

---

| | |
|:---|:---|
| **Top 10 Underlying Obligors** | **Top 10 Underlying Obligors** |
| **Obligor** | **% Total** |
| TransDigm | 0.60% |
| Hologic | 0.46% |
| TIBCO Software | 0.44% |
| Citadel Securities LP | 0.44% |
| Jane Street Group | 0.44% |
| Acrisure | 0.42% |
| Quikrete Companies | 0.41% |
| Sedgwick Claims Management Service | 0.40% |
| Ensemble RCM | 0.40% |
| Belron FIN 2019 | 0.40% |
| **Total** | **4.41%** |

---

---

| | |
|:---|:---|
| **Top 10 Industries of Underlying Obligors** | **Top 10 Industries of Underlying Obligors** |
| **Industry** | **% Total** |
| Healthcare & Pharmaceuticals | 12.13% |
| High Tech | 12.07% |
| Banking, Finance, Insurance & Real Estate | 10.25% |
| Services: Business | 8.62% |
| Hotels, Gaming & Leisure | 5.15% |
| Capital Equipment | 4.81% |
| Beverage, Food & Tobacco | 4.37% |
| Construction & Building | 4.08% |
| Aerospace & Defense | 3.81% |
| Energy: Oil & Gas | 3.66% |
| **Total** | **68.95%** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Weighted Average Rating Distribution Weighted Average Maturity Distribution**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Wtd Avg = B+ Wtd Avg = 4.6 yrs**

![Weighted Average Rating Distribution.jpg](ck0001517767-20260331_g5.jpg)

![Weighted Average Maturity Distribution.jpg](ck0001517767-20260331_g6.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Weighted Average Price Distribution Weighted Average Spread Distribution**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Wtd Avg = 94.32 Wtd Avg = 2.96%**

![Weighted Average Price Distribution.jpg](ck0001517767-20260331_g7.jpg)

![Weighted Average Stated Spread Distribution.jpg](ck0001517767-20260331_g8.jpg)

**FEES AND EXPENSES**

The following table is intended to assist in understanding the costs and expenses that an investor in our common shares

will bear, directly or indirectly, based on the assumptions set forth below. The expenses shown in the table under "Annual

Expenses" are estimated amounts based on historical fees and expenses, as appropriate. We caution that some of the

percentages indicated in the table below are estimates and may vary. Except where the context suggests otherwise, whenever

this table contains a reference to our fees or expenses, we will pay such fees and expenses out of our net assets and,

consequently, shareholders will indirectly bear such fees or expenses as investors in the Fund.

---

| | |
|:---|:---|
| **SHAREHOLDER TRANSACTION FEES** |  |
| Sales load | —%<br><sup>(1)</sup> |
| Offering expenses borne by the Fund  | —%<br><sup>(2)</sup> |
| Dividend reinvestment plan expenses  | —%<br><sup>(3)</sup> |
| **Total shareholder transaction fees** | **—%**<br><sup>(4)</sup> |

---

---

| | |
|:---|:---|
| **ESTIMATED ANNUAL FUND EXPENSES**<br>**(as a percentage of net assets attributable to common shares)**<br>|  |
| Management Fee  | 3.13%<br><sup>(5)</sup> |
| Incentive Fee payable under Investment Advisory Agreement (17.5%) | 1.23%<br><sup>(6)</sup> |
| Interest payments and fees on borrowed funds | 8.73%<br><sup>(7)</sup> |
| Other Expenses | 3.03%<br><sup>(8)</sup> |
| **Total annual fund expenses** | **16.12%** |

---

1. In the event that the Fund sells its securities publicly through underwriters or agents the related prospectus supplement will disclose the

applicable sales load.

2. In the event that the Fund sells its securities publicly through underwriters or agents the related prospectus supplement will disclose the

estimated amount of total offering expenses (which may include offering expenses borne by third parties on the Fund's behalf), the offering

price and the offering expenses borne by the Fund as a percentage of the offering price.

3. The expenses of administering the dividend reinvestment plan (the "DRP") are included in "Other Expenses." Investors will pay brokerage

charges if they direct their broker or the DRP Plan agent to sell their Common Shares that they acquired pursuant to the DRP. See ***"Dividend***

***Reinvestment Plan."***

4. The related prospectus supplement will disclose the offering price and the total stockholder transaction expenses as a percentage of the

offering price.

5. The Management Fee is calculated and payable monthly in arrears at the annual rate of 1.75% of the month-end value of the Fund's managed

Assets. "Managed Assets" means the total assets of the Fund (including any assets attributable to any preferred shares or to indebtedness)

minus the Fund's liabilities other than liabilities relating to indebtedness.

6. The Fund shall pay CGCIM an Incentive Fee calculated and payable quarterly in arrears based upon the Fund's "pre-incentive fee net

investment income" for the immediately preceding quarter, and is subject to a hurdle rate, expressed as a rate of return on the Fund's net

assets, equal to 2.00% per quarter (or an annualized hurdle rate of 8.00%), subject to a "catch-up" feature. For this purpose, "pre-incentive fee

net investment income" means interest income, dividend income, income generated from original issue discounts, payment-in-kind income,

and any other income earned or accrued during the calendar quarter, minus the Fund's operating expenses (which, for this purpose shall not

include any distribution and/or shareholder servicing fees, litigation, any extraordinary expenses or Incentive Fee) for the quarter. For

purposes of computing the Fund's pre-incentive fee net investment income, the calculation methodology will look through total return swaps

as if the Fund owned the referenced assets directly. As a result, the Fund's pre-incentive fee net investment income includes net interest, if

any, associated with a derivative or swap, which is the difference between (a) the interest income and transaction fees related to the reference

assets and (b) all interest and other expenses paid by the Fund to the derivative or swap counterparty. "Net assets" means the total assets of

the Fund minus the Fund's liabilities. For purposes of the Incentive Fee, net assets are calculated for the relevant quarter as the weighted

average of the net asset value of the Fund as of the first business day of each month therein. The weighted average net asset value shall be

calculated for each month by multiplying the net asset value as of the beginning of the first business day of the month times the number of

days in that month, divided by the number of days in the applicable calendar quarter.

The calculation of the Incentive Fee for each calendar quarter is as follows:

• No Incentive Fee is payable to CGCIM if the Fund's pre-incentive fee net investment income, expressed as a percentage

of the Fund's net assets in respect of the relevant calendar quarter, does not exceed the quarterly hurdle rate of 2.00%;

• 100% of the portion of the Fund's pre-incentive fee net investment income that exceeds the hurdle rate but is less than or

equal to 2.4242% (the "catch-up") is payable to CGCIM if the Fund's pre-incentive fee net investment income, expressed

as a percentage of the Fund's net assets in respect of the relevant calendar quarter, exceeds the hurdle rate but is less than

or equal to 2.4242% (9.6968% annualized). The "catch-up" provision is intended to provide CGCIM with an incentive fee

of 17.5% on all of the Fund's pre-incentive fee net investment income when the Fund's pre-incentive fee net investment

income reaches 2.4242% of net assets; and

• 17.5% of the portion of the Fund's pre-incentive fee net investment income that exceeds the "catch-up" is payable to

CGCIM if the Fund's pre-incentive fee net investment income, expressed as a percentage of the Fund's net assets in

respect of the relevant calendar quarter, exceeds 2.4242% (9.6968% annualized). As a result, once the hurdle rate is

reached and the catch-up is achieved, 17.5% of all the Fund's pre-incentive fee net investment income thereafter is

allocated to CGCIM.

7. The Fund may issue preferred shares or debt securities. The above figure assumes an aggregate of $3.5 million of the Fund's Series B

Convertible Preferred Shares with an interest rate of 7.125% per annum, $30.0 million of the Fund's Series D Term Preferred Shares with an

interest rate of 7.375%, and $17.5 million of the Fund's Series E Convertible Preferred Shares with an interest rate of 7.25%. In the event that

the Fund were to issue additional preferred shares or debt securities, the Fund's borrowing costs, and correspondingly its total annual

expenses, including, in the case of such preferred shares, the base management fee as a percentage of the Fund's net assets attributable to

common shares, would increase.

8."Other expenses" includes the Fund's overhead expenses, including payments under the Administration Agreement based on the Fund's

allocable portion of overhead and other expenses incurred by Administrator, and payment of fees in connection with outsourced

administrative functions, and are based on estimated amounts for the current fiscal year. "Other expenses" also includes the ongoing

administrative expenses to the independent accountants and legal counsel of the Fund, compensation of independent directors, and costs and

expenses relating to rating agencies.

The following examples illustrate the hypothetical expenses that would be paid on a $1,000 investment assuming

annual expenses attributable to common shares remain unchanged and common shares earn a 5% annual return:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Example** | **<u>1 Year</u>** | **<u>3 Years</u>** | **<u>5 Years</u>** | **<u>10 Years</u>** |
| Expenses on a $1,000 investment, assuming a 5% <br>annual return<br>| $165 | $441 | $657 | $1012 |

---

The example and the expenses in the tables above should not be considered a representation of the Fund's future expenses, and

actual expenses may be greater or less than those shown. While the example assumes a 5.0% annual return, as required by the

SEC, the Fund's performance will vary and may result in a return greater or less than 5.0%.

**CARLYLE CREDIT INCOME FUND**

**STATEMENT OF ASSETS AND LIABILITIES (Unaudited)**

**As of March 31, 2026** 

(expressed in U.S. dollars)

---

| | |
|:---|:---|
|  | **March 31, 2026** |
| **ASSETS** |  |
| Investments, at fair value (cost $174,665,811) | $122889556 |
| Cash and cash equivalents | 2812913 |
| Interest receivable | 3610272 |
| Deferred financing costs | 560107 |
| Prepaid expenses | 163490 |
| Total assets | $130036338 |
| **LIABILITIES** |  |
| Preferred Shares (net of unamortized deferred issuance costs of $1,744,233) (Note 7) | $49272767 |
| Secured credit facility | 8000000 |
| Incentive fee payable | 253737 |
| Management fee payable | 393621 |
| Professional fees payable | 309736 |
| Interest payable | 261081 |
| Administration and custodian fees payable | 256427 |
| Other payables and accrued expenses | 439495 |
| Total liabilities | $59186864 |
| **COMMITMENTS AND CONTINGENCIES (Note 8)** |  |
| **Net Assets** | **$70849474** |
| **COMPOSITION OF NET ASSETS** |  |
| Paid-in capital | $151629695 |
| Total distributable earnings (losses) | (80780221) |
| **Total Net Assets** | **$70849474** |
| **Common shares outstanding (no par value)** | **21198622** |
| **Net asset value per share of common stock** | **$3.34** |

---

*See accompanying Notes to Financial Statements.* 

**CARLYLE CREDIT INCOME FUND**

**SCHEDULE OF INVESTMENTS (Unaudited)**

**As of March 31, 2026**

(expressed in U.S. dollars)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Issuer** <sup>(1)(7)</sup> | **Investment Description** | **Acquisition** <br>**Date** <sup>(2)</sup><br>| **Principal** <br>**Amount**<br>| **Cost** | **Fair Value** <sup>(3)</sup> | **% of Net** <br>**Assets**<br>|
| **CLO - Equity**<sup>(4)(5)</sup> |  |  |  |  |  |  |
| 522 Funding CLO 2021-7, Ltd. | Subordinated Notes (effective yield 0.00%, <br>4/23/2034)<sup>8</sup><br>| 7/27/2023 | $4505000 | $266073 | $27030 | 0.04% |
| AGL CLO 17, Ltd. | Subordinated Notes (effective yield 9.76%, <br>1/21/2035)<br>| 5/6/2024 | 2750000 | 1802209 | 805166 | 1.15% |
| Aimco CLO 10, Ltd. | Subordinated Notes (effective yield 8.27%, <br>7/22/2032)<br>| 11/27/2023 | 11071800 | 5860213 | 4484055 | 6.33% |
| Aimco CLO 14, Ltd. | Subordinated Notes (effective yield 10.23%, <br>10/20/2038)<br>| 7/17/2023 | 6200000 | 4543138 | 3581394 | 5.05% |
| Allegro XVII, Ltd. | Subordinated Notes (effective yield 13.70%, <br>7/25/2038)<br>| 5/07/2025 | 1875000 | 1488932 | 1134987 | 1.60% |
| Apidos CLO XXV, Ltd. | Subordinated Notes (effective yield 0.00%, <br>1/20/2037)<sup>8</sup><br>| 7/1/2025 | 6000000 | 1769368 | 1496784 | 2.11% |
| Apidos CLO XXXIII, Ltd. | Subordinated Notes (effective yield 9.87%, <br>10/24/2034)<sup>6</sup><br>| 7/25/2024 | 22780000 | 12053371 | 9770868 | 13.79% |
| Apidos CLO XXXIX, Ltd. | Subordinated Notes (effective yield 11.18%, <br>10/21/2038)<br>| 5/2/2024 | 7058000 | 4477670 | 3548254 | 5.01% |
| Ares LIX CLO, Ltd. | Subordinated Notes (effective yield 18.85%, <br>4/25/2034)<br>| 12/7/2023 | 8000000 | 4125084 | 2231943 | 3.15% |
| Ares LV CLO, Ltd. | Subordinated Notes (effective yield 11.40%, <br>10/15/2037)<br>| 8/19/2025 | 7500000 | 5055380 | 3330010 | 4.70% |
| Ares LVI CLO, Ltd. | Subordinated Notes (effective yield 14.14%, <br>1/25/2038)<br>| 8/24/2023 | 4751000 | 2726273 | 2076736 | 2.93% |
| Ares LX CLO, Ltd. | Subordinated Notes (effective yield 21.35%, <br>7/18/2034)<br>| 11/29/2023 | 1600000 | 745336 | 461279 | 0.65% |
| Ares LXXIV CLO, Ltd. | Subordinated Notes (effective yield 11.22%, <br>10/15/2037)<br>| 7/23/2025 | 4000000 | 3141285 | 1898956 | 2.68% |
| Audax CLO 12, Ltd. | Subordinated Notes (effective yield 18.77%, <br>4/22/2037)<br>| 3/03/2025 | 1330000 | 1215547 | 1123208 | 1.59% |
| Ballyrock CLO 16, Ltd. | Subordinated Notes (effective yield 12.36%, <br>7/20/2034)<br>| 8/20/2024 | 5867000 | 3206398 | 2308931 | 3.26% |
| Ballyrock CLO 18, Ltd. | Subordinated Notes (effective yield 9.68%, <br>4/15/2038)<br>| 8/16/2023 | 3260000 | 1844252 | 1063243 | 1.50% |
| Barings CLO, Ltd. 2019-III | Subordinated Notes (effective yield 15.31%, <br>1/20/2036)<sup>6</sup><br>| 12/13/2023 | 7695466 | 3405880 | 2122282 | 3.00% |
| Barings CLO, Ltd. 2021-I | Subordinated Notes (effective yield 0.00%, <br>4/25/2034)<sup>8</sup><br>| 7/17/2023 | 3400000 | 1459569 | 760407 | 1.07% |
| Barings CLO, Ltd. 2025-I | Subordinated Notes (effective yield 11.47%, <br>4/20/2038)<br>| 2/14/2025 | 6000000 | 4867473 | 3781959 | 5.34% |
| Barings CLO, Ltd. 2025-VIII | Subordinated Notes (effective yield 14.24%, <br>1/15/2039)<br>| 12/03/2025 | 3600000 | 2859120 | 2758281 | 3.89% |
| Benefit Street Partners CLO XXIII, <br>Ltd.<br>| Subordinated Notes (effective yield 20.08%, <br>4/25/2034)<br>| 8/02/2023 | 10000000 | 5995262 | 5182323 | 7.31% |
| Benefit Street Partners CLO <br>XXXVIII, Ltd.<br>| Subordinated Notes (effective yield 8.88%, <br>1/25/2038)<br>| 12/17/2024 | 5000000 | 4577254 | 3361870 | 4.75% |
| Birch Grove CLO 3, Ltd. | Subordinated Notes (effective yield 9.14%, <br>1/19/2038)<br>| 9/4/2024 | 8602500 | 6774666 | 4376618 | 6.18% |
| CIFC Funding 2020-II, Ltd. | Subordinated Notes (effective yield 11.49%, <br>10/20/2034)<br>| 2/11/2025 | 9032000 | 4567308 | 3470369 | 4.91% |
| Elmwood CLO 17, Ltd. | Subordinated Notes (effective yield 8.62%, <br>7/17/2037)<br>| 8/13/2025 | 17500000 | 11177036 | 9262543 | 13.07% |
| Elmwood CLO VII, Ltd. | Subordinated Notes (effective yield 5.36%, <br>1/17/2034)<br>| 7/17/2023 | 3400000 | 1542041 | 827546 | 1.17% |
| Empower CLO 2022-1, Ltd. | Subordinated Notes (effective yield 9.46%, <br>10/20/2037)<br>| 9/27/2024 | 9500000 | 7233696 | 4181068 | 5.90% |
| Galaxy XXII CLO, Ltd. | Subordinated Notes (effective yield 6.31%, <br>4/16/2034)<br>| 12/15/2023 | 3560000 | 1923511 | 986151 | 1.39% |
| MidOcean Credit CLO XI, Ltd. | Subordinated Notes (effective yield 14.23%, <br>1/18/2036)<br>| 1/12/2024 | 6250000 | 3713384 | 2275269 | 3.21% |
| MidOcean Credit CLO XIV, Ltd. | Subordinated Notes (effective yield 8.10%, <br>4/15/2037)<sup>6</sup><br>| 2/15/2024 | 6750000 | 4299873 | 2936473 | 4.14% |
| Neuberger Berman Loan Advisers <br>CLO 41, Ltd.<br>| Subordinated Notes (effective yield 12.45%, <br>4/15/2034)<br>| 11/1/2023 | 4500000 | 2402581 | 1298962 | 1.83% |
| Niagara Park CLO, Ltd. | Subordinated Notes (effective yield 15.25%, <br>1/17/2038)<br>| 12/1/2023 | 7850000 | 4268420 | 2694351 | 3.80% |

---

**CARLYLE CREDIT INCOME FUND**

**SCHEDULE OF INVESTMENTS (Unaudited)**

**As of March 31, 2026**

(expressed in U.S. dollars)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Issuer** <sup>(1)(7)</sup> | **Investment Description** | **Acquisition** <br>**Date** <sup>(2)</sup><br>| **Principal** <br>**Amount**<br>| **Cost** | **Fair Value** <sup>(3)</sup> | **% of Net** <br>**Assets**<br>|
| Niagara Park CLO, Ltd. | Subordinated Notes (effective yield 11.67%, <br>1/17/2038)<br>| 11/6/2024 | $79398 | $77177 | $77100 | 0.11% |
| Oaktree CLO 2019-3, Ltd. | Subordinated Notes (effective yield 11.96%, <br>1/20/2038)<br>| 6/12/2025 | 3500000 | 1991588 | 1238292 | 1.76% |
| OCP CLO 2015-9, Ltd. | Subordinated Notes (effective yield 11.29%, <br>1/15/2037)<br>| 12/6/2023 | 21847700 | 7806134 | 5399162 | 7.62% |
| OCP CLO 2017-13, Ltd. | Subordinated Notes (effective yield 7.18%, <br>11/26/2037)<br>| 5/13/2025 | 17897237 | 5818714 | 4508360 | 6.36% |
| OHA Credit Partners XIII, Ltd. | Subordinated Notes (effective yield 11.65%, <br>10/21/2034)<br>| 7/17/2023 | 2950000 | 1668496 | 1143912 | 1.61% |
| Riverbank Park CLO, Ltd. | Subordinated Notes (effective yield 12.81%, <br>1/25/2038)<br>| 11/4/2025 | 9950000 | 7583726 | 5621025 | 7.93% |
| RR 12, Ltd. | Subordinated Notes (effective yield 0.00%, <br>1/15/2036)<sup>8</sup><br>| 7/31/2024 | 8542000 | 1457461 | 983474 | 1.39% |
| RR 6, Ltd. | Subordinated Notes (effective yield 0.00%, <br>4/15/2036)<sup>8</sup><br>| 4/25/2024 | 2206250 | 708449 | 144055 | 0.20% |
| Silver Point CLO 4, Ltd. | Subordinated Notes (effective yield 14.64%, <br>4/15/2037)<br>| 2/28/2025 | 7140000 | 4480506 | 1843769 | 2.60% |
| Voya CLO 2020-2, Ltd. | Subordinated Notes (effective yield 11.22%, <br>7/19/2034)<br>| 8/02/2023 | 13597500 | 9740815 | 7235149 | 10.21% |
| Voya CLO 2020-3, Ltd. | Subordinated Notes (effective yield 10.62%, <br>1/20/2038)<br>| 8/3/2023 | 5798000 | 3710656 | 2673436 | 3.77% |
| **Total CLO Equity** |  |  |  | **$170431325** | **$120487050** | **170.06%** |
| **CLO - Debt**<sup>(4)</sup> |  |  |  |  |  |  |
| Apidos CLO XXXIII, Ltd. | 12.22% (3M Term SOFR + 8.55%, <br>4/24/2038)<br>| 4/23/2025 | $250000 | $230607 | $227506 | 0.32% |
| **Total CLO Debt** |  |  |  | **$230607** | **$227506** | **0.32%** |
| **Real Estate**<sup>(9)</sup> |  |  |  |  |  |  |
| Moores Crossing - Travis County, TX |  | 7/14/2023 | $4000000 | $4003879 | $2175000 | 3.07% |
| **Total Real Estate** |  |  |  | **$4003879** | **$2175000** | **3.07%** |
| **Total Investments** |  |  |  | **$174665811** | **$122889556** | **173.45%** |
| **Cash Equivalents** |  |  |  |  |  |  |
| City National Bank MMDA | Money Market Deposit Account |  | $2037879 | $2037879 | $2037879 | 2.88% |
| U.S. Bank MMDA | Money Market Deposit Account  |  | 775034 | 775034 | 775034 | 1.09% |
| **Total Cash Equivalents** |  |  |  | **$2812913** | **$2812913** | **3.97%** |
| **Total Investments and Cash** <br>**Equivalents**<br>|  |  |  | **$177478724** | **$125702469** | **177.42%** |

---

(1) The Fund is not affiliated with, nor does it "control" (as such term is defined in the Investment Company Act of 1940 (the "1940 Act")) any of

the issuers listed. In general, under the 1940 Act, the Fund would be presumed to "control" an issuer if it owned 25% or more of its voting

securities.

(2) Acquisition date represents the initial date of purchase or the date the investment was contributed to the Fund at the time of the Fund's

formation.

(3) Fair value is determined by the Adviser in accordance with the written valuation policies and procedures, subject to oversight by the Fund's

Board of Trustees, in accordance with Rule 2a-5 under the 1940 Act.

(4) Securities exempt from registration under the Securities Act of 1933, and are deemed to be "restricted securities." As of March 31, 2026, the

aggregate fair value of these securities is $120,714,556, or 170.38% of the Fund's net assets.

(5) CLO subordinated notes and subordinated fee notes are considered CLO equity positions. CLO equity positions are entitled to recurring

distributions which are generally equal to the remaining cash flow of payments made by underlying assets less contractual payments to debt

holders and fund expenses. The effective yield is estimated based upon the current projection of the amount and timing of these recurring

distributions in addition to the estimated amount of terminal principal payment. It is the Fund's policy to calculate the effective yield for each

CLO equity position held within the Fund's portfolio at the initiation of each investment and to update it each subsequent quarter thereafter.

The effective yield and investment cost may ultimately not be realized. As of March 31, 2026, the Fund's weighted average effective yield on

its aggregate CLO equity positions, based on current amortized cost, was 11.06%. When excluding called CLOs, the Fund's weighted average

effective yield on its CLO equity positions was 11.44%.

(6) Fair value includes the Fund's interests in fee rebates on the CLO subordinated notes.

(7) The fair value of the investment was determined using significant unobservable inputs. See "Note 3. Fair Value Measurements."

**CARLYLE CREDIT INCOME FUND**

**SCHEDULE OF INVESTMENTS (Unaudited)**

**As of March 31, 2026**

(expressed in U.S. dollars)

(8) As of March 31, 2026, the investment has been called. Expected value of residual distributions, once received, is anticipated to be recognized

as return of capital, pending any remaining amortized cost, and/or realized gain for any amounts received in excess of such amortized cost.

(9) The Fund inherited a non-income producing defaulted real estate loan from VCIF that was not included in the legacy portfolio sale. Pursuant

to a deed-in-lieu of foreclosure on August 10, 2023, the Fund has ownership of the real estate.

*See accompanying Notes to Financial Statements.*

**CARLYLE CREDIT INCOME FUND**

**STATEMENT OF OPERATIONS (Unaudited)**

**For the Six Months Ended March 31, 2026**

(expressed in U.S. dollars)

---

| | |
|:---|:---|
|  | **Six Months Ended** <br>**March 31, 2026**<br>|
| **Investment Income** |  |
| Interest income | $12661704 |
| Total investment income | 12661704 |
| **Expenses** |  |
| Interest expense | 5539868 |
| Management fees | 1572708 |
| Incentive fees | 253737 |
| Professional fees | 659687 |
| Administration and custodian fees | 331722 |
| Insurance expense | 119173 |
| Printing expense | 85565 |
| Transfer agent fees | 89255 |
| Trustees' fees and expenses | 62329 |
| Other expenses | 58757 |
| Total expenses | 8772801 |
| **Net Investment Income** | **3888903** |
| **Net Realized and Unrealized Gain (Loss)** |  |
| Net realized gain (loss) on investments | (12835266) |
| Net change in unrealized appreciation (depreciation) on investments | (37716591) |
| **Net Realized and Unrealized Gain (Loss)** | (50551857) |
| **Net Decrease in Net Assets Attributable to Common Shares from Operations** | **$(46662954)** |

---

*See accompanying Notes to the Financial Statements.*

**CARLYLE CREDIT INCOME FUND**

**STATEMENTS OF CHANGES IN NET ASSETS (Unaudited)**

**For the Six Months Ended March 31, 2026 and for the Year Ended September 30, 2025**

**(**expressed in U.S. dollars)

---

| | | |
|:---|:---|:---|
|  | **Six Months Ended** <br>**March 31, 2026**<br>| **Year Ended** <br>**September 30, 2025**<br>|
| Net increase (decrease) in net assets from operations: |  |  |
| Net investment income | $3888903 | $15208865 |
| Net realized gain (loss) on investment transactions | (12835266) | (17706825) |
| Net change in unrealized appreciation (depreciation) on investments  | (37716591) | (3504909) |
| Net decrease in net assets resulting from operations | (46662954) | (6002869) |
| Distributions to shareholders from: |  |  |
| Net investment income | (12401194) | (10363754) |
| Return of capital |  | (13459803) |
| Total distributions to shareholders | (12401194) | (23823557) |
| Capital share transactions |  |  |
| Net increase (decrease) in net assets resulting from beneficial interest: |  |  |
| Issuance of common shares |  | 40303512 |
| Reinvestment of dividends |  | 1823533 |
| Net increase in net assets from capital share transactions |  | 42127045 |
| Total increase (decrease) in net assets | (59064148) | 12300619 |
| Net assets at the beginning of the period | 129913622 | 117613003 |
| Net assets at the end of the period | **$70849474** | **$129913622** |

---

*See accompanying Notes to Financial Statements.*

**CARLYLE CREDIT INCOME FUND**

**STATEMENT OF CASH FLOWS (Unaudited)**

**For the Six Months Ended March 31, 2026**

**(**expressed in U.S. dollars)

---

| | |
|:---|:---|
|  | **Six Months Ended** <br>**March 31, 2026**<br>|
| **Cash flows from operating activities** |  |
| Net decrease in net assets resulting from operations | $(46662954) |
| Adjustments to reconcile net decrease in net assets from operations to net cash provided by operating activities: |  |
| Purchases of investments, net of change in payable for investments purchased | (14513070) |
| Proceeds from disposition of investments and reductions to investment cost value, net of change in receivable <br>for investments sold <sup>(1)</sup><br>| 44223753 |
| Net amortization on investments | (332) |
| Amortization of deferred issuance costs on preferred shares and credit facility | 2716605 |
| Net realized loss on investments | 12835266 |
| Net change in unrealized depreciation on investments | 37716591 |
| *Changes in assets:* |  |
| Decrease in interest receivable | 2582483 |
| Decrease in prepaid expenses and other assets | 119172 |
| *Changes in liabilities:* |  |
| Decrease in incentive fee payable | (417006) |
| Increase in management fee payable | 87989 |
| Decrease in interest payable on preferred shares | (105147) |
| Decrease in professional fees payable | (429547) |
| Increase in administration and custodian fees payable | 93713 |
| Increase in other payables and accrued expenses | 217195 |
| Net cash provided by operating activities | 38464711 |
| **Cash flows from financing activities** |  |
| Borrowings on credit facility | 18500000 |
| Repayments on credit facility | (17250000) |
| Proceeds from the issuance of preferred shares | 47500000 |
| Deferred issuance costs for the issuance of preferred shares | (2466224) |
| Payments on preferred shares redeemed, net of redemptions payable | (72000000) |
| Dividends paid to shareholders | (12401194) |
| Net cash used in financing activities | (38117418) |
| Net increase in cash and cash equivalents | 347293 |
| Cash and cash equivalents, beginning of period | 2465620 |
| Cash and cash equivalents, end of period | $2812913 |

---

---

| | |
|:---|:---|
| **Supplemental information:** |  |
| Cash paid for interest on preferred shares | $2770675 |

---

(1) Proceeds from the disposition of investments and reductions to investment cost value includes $7,750,707 of return of capital on CLO

equity investments from recurring cash flows and distributions from called deals and refinancings during the six month period ended

March 31, 2026.

*See accompanying Notes to Financial Statements.*

**CARLYLE CREDIT INCOME FUND**

**FINANCIAL HIGHLIGHTS (Unaudited)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Six Months** <br>**Ended March** <br>**31, 2026** | **Year Ended September 30,** | **Year Ended September 30,** | **Year Ended September 30,** | **Year Ended September 30,** |
|  | **Six Months** <br>**Ended March** <br>**31, 2026** | **2025** | **2024** | **2023**<sup>(7)</sup> | **2022** |
| **Per Share Operating Data** |  |  |  |  |  |
| Net asset value, beginning of period | $6.13 | $7.64 | $8.42 | $10.39 | $11.69 |
| Income (loss) from investment operations: |  |  |  |  |  |
| Net investment income <sup>(1)</sup> | 0.18 | 0.81 | 1.19 | 0.05 | 0.50 |
| Net realized and unrealized gain (loss) <sup>(2)</sup> | (2.38) | (1.13) | (0.74) | (1.20) | (0.80) |
| Total from investment operations | (2.20) | (0.32) | 0.45 | (1.15) | (0.30) |
| Dividends to shareholders from: |  |  |  |  |  |
| Net investment income <sup>(3)</sup> | (0.59) | (0.55) | (0.03) | (0.43) | (0.73) |
| Net realized gains <sup>(3)</sup> |  |  |  |  | (0.18) |
| Return of capital <sup>(3)</sup> |  | (0.71) | (1.20) | (0.40) | (0.09) |
| Total dividends | (0.59) | (1.26) | (1.23) | (0.82) | (1.00) |
| Effect of shares issued | $— | $0.07 | $— | $— | $— |
| Net asset value, end of period | $3.34 | $6.13 | $7.64 | $8.42 | $10.39 |
| Per share market value at beginning of period | $5.82 | $8.23 | $8.18 | $8.92 | $10.49 |
| Per share market value at end of period | $3.21 | $5.82 | $8.23 | $8.18 | $8.92 |
| Total Return based on Net Asset Value <sup>(4)</sup> | (38.29)% | (3.74)% | 6.07% | (11.75)% | (2.77)% |
| Total Return based on Market Value <sup>(5)</sup> | (36.94)% | (15.09)% | 17.21% | 0.39% | (5.95)% |
| **Ratios/Supplemental Data** |  |  |  |  |  |
| Net assets, end of period (in thousands) | $70849 | $129914 | $117613 | $98751 | $107829 |
| Ratio of gross expenses to average net assets <sup>(6)</sup> | 16.68% | 13.85% | 12.92% | 7.42% | 3.27% |
| Ratio of net expenses to average net assets <sup>(6)</sup> | 16.68% | 13.85% | 12.92% | 6.72% | 3.09% |
| Ratio of net expenses before incentive fees to average net <br>assets <sup>(6)</sup><br>| 16.20% | 11.36% | 9.72% | N/A | N/A |
| Ratio of net investment income to average net assets <sup>(6)</sup> | 7.39% | 11.72% | 15.10% | 0.56% | 4.53% |
| Portfolio turnover rate | 17.33% | 28.91% | 17.69% | 100.91% | 28.39% |
| Asset coverage of preferred shares and credit facility | 220% | 258% | 285% | N/A | N/A |
| Loan Outstanding, End of Year/Period (in thousands) <sup>(8)</sup> | $8000 | $6750 | N/A | N/A | $7455 |
| Asset Coverage Ratio for Loan Outstanding <sup>(8)</sup> | 1,623% | 3,143% | N/A | N/A | 1,546% |
| Asset Coverage, per $1,000 Principal Amount of Loan <br>Outstanding <sup>(8)</sup><br>| $16233 | $31434 | N/A | N/A | $15463 |
| Weighted Average Loans Outstanding (in thousands) <sup>(8)</sup> | $2526 | $7542 | N/A | $3732 | $8051 |
| Weighted Average Interest Rate on Loans Outstanding <sup>(8)</sup> | 7.09% | 7.45% | N/A | 7.94% | 4.50% |

---

(1) Per share amounts are calculated based on the average shares outstanding during the period.

(2) Net realized and unrealized gain (loss) includes adjustments to reconcile change in net asset value ("NAV") per share. The amount may

not agree with the change in the aggregate net realized and unrealized gain (loss) due to the timing of the issuance of the Fund's common

shares in relation to fluctuating market values for the portfolio.

(3) Management monitors available taxable earnings to determine if a tax return of capital may occur for the period. To the extent the Fund's

taxable earnings fall below the total amount of the Fund's distributions for that fiscal year, a portion of those distributions may be deemed

a tax return of capital to the Fund's shareholders. The ultimate tax character of the Fund's earnings cannot be determined until tax returns

are prepared after the end of the fiscal year.

(4) Total return based on net asset value (not annualized) is based on the change in net asset value per common share during the year plus the

declared dividends on common stock, assuming reinvestment of dividends in accordance with the dividend reinvestment plan, divided by

the beginning net asset value for the period. Had the Adviser not waived expenses, total returns would have been lower. Returns do not

reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares.

(5) Total return based on market value (not annualized) is calculated as the change in market value per common share during the period plus

the declared dividends on common stock, assuming reinvestment of dividends in accordance with the dividend reinvestment plan, divided

by the beginning market price for the period. Had the Adviser not waived expenses, total returns would have been lower. Returns do not

reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares.

(6) Annualized for periods less than one full year. For years ended September 2022 and 2023, the Fund waived certain expenses in

connection with an expense limitation agreement. For the six month period ended March 31, 2026, there were no expenses waived. See

Note 4. *Related Party Transactions,* for further information.

**CARLYLE CREDIT INCOME FUND**

**FINANCIAL HIGHLIGHTS (Continued)**

(7) Effective at the close of business on July 14, 2023, CGCIM replaced Oakline Advisors as the Fund's new investment adviser and the

Fund's investment strategy was changed to invest primarily in debt and equity tranches issued by collateralized loan obligations. Prior to

the close of business on July 14, 2023, the investment strategy was to invest primarily in mortgage notes secured by residential real estate.

(8) On July 11, 2025, the Fund entered into a revolving credit and security agreement (the "Credit Facility"). The weighted average loans

outstanding and weighted average interest rate on loans outstanding were calculated from August 13, 2025 (initial date the Fund borrowed

under the Credit Facility) through September 30, 2025 for the year ended September 30, 2025. The obligations under the Credit Facility

are secured by a first priority lien on substantially all of the Fund's portfolio investments (see Note 6, Borrowings). A revolving line of

credit agreement between the Fund and Nexbank was terminated on July 5, 2023.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Senior Securities** | | | | |
| **Class and Period Ended** | <br>**Total Amount** <br>**Outstanding** <br>**Exclusive of** <br>**Treasury** <br>**Securities**<sup>(1)</sup><br>| <br>**Asset** <br>**Coverage** <br>**Per Unit** <sup>(2)</sup><br>| <br>**Involuntary** <br>**Liquidating** <br>**Preference** <br>**Per Unit** <sup>(3)</sup><br>| <br>**Average** <br>**Market Value** <br>**Per Unit** <sup>(4)</sup><br>|
| **Credit Facility** |  |  |  |  |
| March 31, 2026 | $8000000 | $16233.31 | $— | N/A |
| September 30, 2025 | $6750000 | $31434.17 | $— | N/A |
| **8.75% Series A Term Preferred Shares** |  |  |  |  |
| September 30, 2025 | $52000000 | $64.48 | $25.00 | $25.74 |
| September 30, 2024 | $52000000 | $71.29 | $25.00 | $25.60 |
| **7.125% Series B Convertible Preferred** <br>**Shares**<br>|  |  |  |  |
| March 31, 2026 | $3517000 | $2200.49 | $1000.00 | N/A |
| September 30, 2025 | $3517000 | $2579.17 | $1000.00 | N/A |
| September 30, 2024 | $11517000 | $2851.68 | $1000.00 | N/A |
| **7.50% Series C Convertible Preferred** <br>**Shares**<br>|  |  |  |  |
| September 30, 2025 | $20000000 | $2579.17 | $1000.00 | N/A |
| **7.375% Series D Term Preferred Shares** |  |  |  |  |
| March 31, 2026 | $30000000 | $55.01 | $25.00 | $25.17 |
| **7.25% Series E Convertible Preferred** <br>**Shares**<br>|  |  |  |  |
| March 31, 2026 | $17500000 | $2200.49 | $1000.00 | N/A |

---

(1) Total amount of each class of senior securities outstanding at principal value at the end of the period presented.

(2) Asset coverage per unit is the ratio of the carrying value of the Fund's total assets, less all liabilities and indebtedness not represented by senior securities, to

the aggregate amount of the outstanding senior securities as calculated in accordance with Section 18(h) of the 1940 Act. The asset coverage per unit figure

is expressed in terms of dollar amounts per share of outstanding Preferred Shares (based on a per share liquidation preference of $25 in the case of the

8.75% Series A Term Preferred Shares and 7.375% Series D Term Preferred Shares, and $1,000 in the case of the 7.125% Series B Convertible Preferred

Shares, 7.50% Series C Convertible Preferred Shares and the 7.25% Series E Convertible Preferred Shares). With respect to the Credit Facility, the asset

coverage ratio is multiplied by $1,000 to determine the asset coverage per unit.

(3) The amount to which such class of senior security would be entitled upon our involuntary liquidation in preference to any security junior to it.

(4) The average market value per unit is calculated by taking the average of the closing price of the 8.75% Series A Term Preferred Shares (NYSE: CCIA) and

the 7.375% Series D Term Preferred Shares (NYSE: CCID) for each day during the year for which they were listed on the NYSE. Not applicable for the

7.125% Series B Convertible Preferred Shares, the 7.50% Series C Convertible Preferred Shares, the 7.25% Series E Convertible Preferred Shares, and the

Credit Facility as they do not have market quoted levels.

*See accompanying Notes to Financial Statements.*

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Unaudited)**

**1. ORGANIZATION**

Carlyle Credit Income Fund (the "Fund") is a non-diversified, closed-end management investment company registered

under the Investment Company Act of 1940, as amended (the "1940 Act"). The Fund was organized as a Delaware statutory

trust on April 8, 2011. In addition, the Fund has elected to be treated, and intends to continue to comply with the requirements

to qualify annually, as a regulated investment company ("RIC") under Subchapter M of the Internal Revenue Code of 1986, as

amended (together with the rules and regulations promulgated thereunder, the "Code"). The Fund currently has one class of

common shares which commenced operations on December 30, 2011. The Fund was previously named Vertical Capital Income

Fund ("VCIF") and was managed by its Adviser, Oakline Advisors LLC ("Oakline"). Effective at the close of business on July

14, 2023, the Fund is managed by its Adviser, Carlyle Global Credit Investment Management L.L.C. ("CGCIM" or the

"Adviser"), a wholly owned subsidiary of Carlyle Investment Management L.L.C.

On January 12, 2023, the Fund entered into a definitive agreement (the "Transaction Agreement") with the Adviser

pursuant to which, among other things, CGCIM would become the investment adviser to the Fund (the "Transaction"). Pursuant

to the Transaction Agreement, the investment advisory agreement between the Fund and Oakline terminated at or near the

closing of the Transaction (the "Closing"). As a result, the holders of the Fund's common shares ("Shareholders") were asked

to approve a new investment advisory agreement between the Fund and CGCIM and to approve certain other proposals upon

which the Closing was conditioned. The Shareholders approved the new Investment Advisory Agreement and the other

proposals at a shareholder meeting on June 15, 2023, followed by the Closing, which occurred on July 14, 2023. In connection

with Closing, (i) the Fund sold existing investments with a gross asset value equal to approximately 97% of the total gross asset

value of such investments as of August 31, 2022, subject to certain exclusions; (ii) CGCIM replaced Oakline as the Fund's new

investment adviser; (iii) the Fund's investment strategy was changed to invest primarily in debt and equity tranches issued by

collateralized loan obligations; (iv) each of the Fund's trustees and officers were replaced; (v) the Fund changed its name on

July 14, 2023 from Vertical Capital Income Fund to Carlyle Credit Income Fund; and (vi) on July 27, 2023 the Fund's common

shares began trading on NYSE under the symbol "CCIF." In addition, Shareholders of the Fund received a special one-time

payment of $10,000,000 from CGCIM (or one of its affiliates), or approximately $0.96 per common share.

Following the closing of the Transaction and pursuant to the Transaction Agreement, (i) CG Subsidiary Holdings

L.L.C., an affiliate of the Adviser (the "Purchaser") commenced a tender offer on July 18, 2023 to purchase up to $25,000,000

of outstanding Fund common shares at the then-current net asset value per common share (the "Tender Offer"), and (ii) the

Purchaser agreed to invest $15,000,000 into the Fund through the purchase of newly issued Fund common shares at a price

equal to the greater of the then-current net asset value per common share and the net asset value per common share that

represents the tender offer purchase price (the "New Issuance"), and through acquiring common shares in private purchases (the

"Private Purchase").

The Tender Offer expired on August 28, 2023, and the Purchaser accepted for purchase 3,012,049 common shares at a

purchase price of $8.30 per common share for an aggregate purchase price of $25,000,007, excluding fees and expenses relating

to the Tender Offer.

On September 12, 2023, the Fund closed the New Issuance and issued and sold 1,269,537 common shares to the

Purchaser at a purchase price of $8.52 per common share, which price represented the net asset value per common share as of

the closing of the New Issuance, for an aggregate purchase price of $10,816,451.

On September 12, 2023, the Purchaser closed the Private Purchase and acquired 504,042 common shares from existing

shareholders of the Fund.

Prior to the close of business on July 14, 2023, the Fund's investment objective was to generate income by primarily

investing in mortgage notes secured by residential real estate. Following the closing of the Transaction, the Fund's primary

investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks

to achieve its investment objectives by investing primarily in equity and junior debt tranches of collateralized loan obligations

("CLO") that are collateralized by a portfolio consisting primarily of below investment grade U.S. senior secured loans with a

large number of distinct underlying borrowers across various industry sectors. The Fund may also invest in other related

securities and instruments or other securities and instruments that the Adviser believes are consistent with its investment

objectives, including senior debt tranches of CLOs, loan accumulation facilities ("LAFs") and securities issued by other

securitization vehicles, such as collateralized bond obligations, or "CBOs." LAFs are short- to medium-term facilities often

provided by the bank that will serve as the placement agent or arranger on a CLO transaction. LAFs typically incur leverage

between four and six times equity value prior to a CLO's pricing. The CLO securities in which the Fund primarily seek to

invest are unrated or rated below investment grade and are considered speculative with respect to timely payment of interest and

repayment of principal. Unrated and below investment grade securities are also sometimes referred to as "junk" securities. In

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

addition, the CLO equity and junior debt securities in which the Fund invests are highly leveraged (with CLO equity securities

typically being leveraged ten times), which magnifies the Fund's risk of loss on such investments.

To qualify as a RIC, the Fund must, among other things, meet certain source-of-income and asset diversification

requirements and timely distribute to its shareholders generally at least 90% of its investment company taxable income, as

defined by the Code, for each year. Pursuant to this election, the Fund generally does not have to pay corporate level taxes on

any income that it distributes to shareholders, provided that the Fund satisfies those requirements.

**2. SIGNIFICANT ACCOUNTING POLICIES**

*Basis of Presentation*

The financial statements have been prepared on the accrual basis of accounting in accordance with accounting

principles generally accepted in the United States ("U.S. GAAP"). The Fund is an investment company for the purposes of

accounting and financial reporting in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards

Codification ("ASC") Topic 946, *Financial Services—Investment Companies* ("ASC 946")*.* U.S. GAAP for an investment

company requires investments to be recorded at fair value. With the exception of the line item entitled "preferred shares" which

is reported at amortized cost, the carrying value for all other assets and liabilities approximates their fair value. The Fund's

fiscal year ends on September 30, and unless otherwise noted, references to fiscal year or year are for fiscal years ended

September 30.

*Use of Estimates*

The preparation of the financial statements in conformity with U.S. GAAP requires management to make assumptions

and estimates that affect the reported amounts in the financial statements and accompanying notes. Management's estimates are

based on historical experiences and other factors, including expectations of future events that management believes to be

reasonable under the circumstances. It also requires management to exercise judgment in the process of applying the Fund's

accounting policies.

*Investments*

Investment transactions are recorded as of the applicable trade date. Realized gains or losses are measured by the

difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment using the

specific identification method without regard to unrealized appreciation or depreciation previously recognized, and includes

investments charged off during the period, net of recoveries. Net change in unrealized appreciation or depreciation on

investments as presented in the accompanying Statement of Operations reflects the net change in the fair value of investments,

including the reversal of previously recorded unrealized appreciation or depreciation when gains or losses are realized. See

Note 3. *Fair Value Measurements,* for further information.

*Cash and Cash Equivalents*

Cash and cash equivalents consist of demand deposits and highly liquid investments (e.g., money market funds, U.S.

Treasury notes) with original maturities of three months or less. The Fund's cash and cash equivalents are held at one or more

large financial institutions and cash held in such financial institutions may, at times, exceed the Federal Deposit Insurance

Corporation insured limit. The Fund classifies cash equivalents as Level I in the fair value hierarchy. Cash equivalents are

carried at cost or amortized cost which approximates fair value.

*Interest from Investments*

CLO equity investments recognize investment income by utilizing an effective interest methodology based upon an

effective yield to maturity utilizing projected cash flow, as required by ASC Topic 325-40, *Beneficial Interest in Securitized* 

*Financial Assets*. The Fund monitors the expected residual payments, and effective yield is determined and updated

periodically, as needed. Accordingly, investment income recognized on CLO equity securities in the U.S. GAAP statement of

operations differs from both the tax-basis investment income and from the cash distributions actually received by the Fund

during the quarterly period.

Interest income is recorded on an accrual basis and includes the accretion of discounts and amortization of premiums.

Discounts from and premiums to par value on debt investments purchased are accreted/amortized into interest income over the

life of the respective security using the effective interest method. The amortized cost of debt investments represents the original

cost, including origination fees and upfront fees received that are deemed to be an adjustment to yield, adjusted for the accretion

of discounts and amortization of premiums, if any.

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

*Interest Expense*

Interest expense includes the Fund's dividends associated with its 8.75% Series A Term Preferred Shares (the "Series

A Term Preferred Shares"), its 7.125% Series B Convertible Preferred Shares (the "Series B Convertible Preferred Shares"), its

7.50% Series C Convertible Preferred Shares (the "Series C Convertible Preferred Shares"), its 7.375% Series D Term

Preferred Shares (the "Series D Term Preferred Shares"), its 7.25% Series E Convertible Preferred Shares (the "Series E

Convertible Preferred Shares"), and its Credit Facility. Interest expense also includes the Fund's amortization of deferred

issuance costs associated with its Series A Term Preferred Shares, its Series B Convertible Preferred Shares, its Series C

Convertible Preferred Shares, its Series D Term Preferred Shares, its Series E Convertible Preferred Shares, and its Credit

Facility.

*Prepaid Expenses*

Prepaid expenses consist primarily of insurance premiums and ATM program expenses. See Note 9. *Capital*, for

further information. Insurance premiums are amortized over the term of the current policy. Prepaid ATM program expenses

represent fees and expenses incurred in connection with the ATM program. Such costs are allocated pro-rata based on the

amount issued relative to the total respective offering amount and are charged to paid-in-capital. Any remaining prepaid

expense balance associated with the ATM program is charged to expense at the earlier of the end of the program period, or at

the effective date of a new ATM program.

*Preferred Shares* (See Note 7. *Preferred Shares,* for further information)

The Fund authorized and issued its Series A Term Preferred Shares and its Series B Convertible Preferred Shares

during the year ended September 30, 2024. The Fund authorized and issued its Series C Convertible Preferred Shares during the

year ended September 30, 2025. The Fund authorized and issued its Series D Term Preferred Shares and its Series E

Convertible Preferred Shares during the six month period ended March 31, 2026. The Fund carries its mandatory redeemable

Series A Term Preferred Shares, Series B Convertible Preferred Shares, Series C Convertible Preferred Shares, Series D Term

Preferred Shares, and Series E Convertible Preferred Shares at amortized cost, and such shares are included as a liability on the

Statement of Assets and Liabilities.

*Deferred Issuance Costs*

Deferred issuance costs consist of fees and expenses incurred in connection with the closing of the Fund's Series A

Term Preferred Shares, Series B Convertible Preferred Shares, Series C Convertible Preferred Shares, Series D Term Preferred

Shares, Series E Convertible Preferred Shares, and the Credit Facility. Deferred issuance costs related to the Series A Term

Preferred Shares and Series D Term Preferred Shares are amortized over the period the shares are outstanding. Deferred

issuance costs related to the Series B Convertible Preferred Shares, Series C Convertible Preferred Shares and Series E

Convertible Preferred Shares are amortized over the shorter of 12 months or the period the shares are outstanding. Deferred

issuance costs related to the Credit Facility are amortized on the straight-line basis over the term of the Credit Facility. The

amortized expenses are included in interest expense in the Fund's financial statements. The unamortized deferred issuance costs

related to the Series A Term Preferred Shares, Series B Convertible Preferred Shares, Series C Convertible Preferred Shares,

Series D Term Preferred Shares, and Series E Convertible Preferred Shares are included on the Fund's Statement of Assets and

Liabilities as a direct deduction from the related preferred share liability. The unamortized balance of such costs related to the

Credit Facility is included in Deferred Issuance Costs on the Fund's Statement of Assets and Liabilities.

*Income Taxes*

For federal income tax purposes, the Fund has elected to be treated as a RIC under the Code, and intends to make the

required distributions to its shareholders as specified therein. In order to qualify as a RIC, the Fund must meet certain minimum

distribution, source-of-income and asset diversification requirements. If such requirements are met, then the Fund is generally

required to pay income taxes only on the portion of its taxable income and gains it does not distribute.

The minimum distribution requirements applicable to RICs require the Fund to distribute to its shareholders at least

90% of its investment company taxable income ("ICTI"), as defined by the Code, each year (the "Annual Distribution

Requirement"). Depending on the level of ICTI earned in a tax year, the Fund may choose to carry forward ICTI in excess of

current year distributions into the next tax year. Any such carryover ICTI must be distributed before the end of that next tax

year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI.

In addition, based on the excise distribution requirements, the Fund is subject to a 4% nondeductible federal excise tax

on undistributed income unless the Fund distributes in a timely manner an amount at least equal to the sum of (1) 98% of its

ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year

period ending October 31 in that calendar year and (3) any income realized, but not distributed, in the preceding year. For this

purpose, however, any ordinary income or capital gain net income retained by the Fund that is subject to corporate income tax

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

is considered to have been distributed. The Fund intends to make sufficient distributions each taxable year to satisfy the excise

distribution requirements.

Due to timing of dividends and distributions, the fiscal year in which amounts are distributed may differ from the fiscal

year in which the income or net realized gain was recorded by the Fund.

*Dividends* 

The composition of distributions paid to common shareholders from net investment income and capital gains are

determined in accordance with U.S. federal income tax regulations, which differ from U.S. GAAP. Distributions to common

shareholders can be comprised of net investment income, net realized capital gains and return of capital for U.S. federal income

tax purposes and are intended to be paid monthly. Distributions payable to common shareholders are recorded as a liability on

ex-dividend date.

The Fund has an "opt out" dividend reinvestment plan ("DRP") that provides for reinvestment of dividends and other

distributions on behalf of the shareholder, other than those shareholders who have "opted out" of the plan. As a result of

adopting the plan, if the Board of Trustees authorizes, and the Fund declares, a cash dividend or distribution, the shareholders

who have not elected to "opt out" of the DRP will have their cash dividends or distributions automatically reinvested in

additional shares of the Fund's shares of beneficial interest, rather than receiving cash. Each registered shareholder may elect to

have such shareholder's dividends and distributions distributed in cash rather than participate in the plan. For any registered

shareholder that does not so elect, distributions on such shareholder's shares will be reinvested by the Transfer Agent, the

Fund's plan administrator, in additional shares. The number of shares to be issued to the shareholder will be determined based

on the total dollar amount of the cash distribution payable, net of applicable withholding taxes.

*Functional Currency*

The functional currency of the Fund is the U.S. Dollar. Investments are generally made in the local currency of the

country in which the investments are domiciled and are translated into U.S. Dollars with foreign currency translation gains or

losses recorded within net change in unrealized appreciation (depreciation) on investments in the accompanying Statement of

Operations.

**3. FAIR VALUE MEASUREMENTS**

The Fund applies fair value accounting in accordance with the terms of FASB ASC Topic 820, *Fair Value* 

*Measurement* ("ASC 820"). ASC 820 defines fair value as the amount that would be exchanged to sell an asset or transfer a

liability in an orderly transfer between market participants at the measurement date. The Fund values securities/instruments

traded in active markets on the measurement date by multiplying the bid price of such traded securities/instruments by the

quantity of shares or amount of the instrument held. The Fund may also obtain quotes with respect to certain of its investments,

such as its securities/instruments traded in active markets and its liquid securities/instruments that are not traded in active

markets, from pricing services, brokers, or counterparties (i.e., "consensus pricing"). When doing so, the Adviser determines

whether the quote obtained is sufficient according to U.S. GAAP to determine the fair value of the security. The Fund may use

the quote obtained or alternative pricing sources may be utilized including valuation techniques typically utilized for illiquid

securities/instruments.

The Board of Trustees has designated the Adviser as the Fund's valuation designee for purposes of Rule 2a-5 under

the Investment Company Act to perform the fair value determination of all of the Fund's assets in accordance with the terms of

ASC 820. Securities/instruments that are illiquid or for which the pricing source does not provide a valuation or methodology or

provides a valuation or methodology that, in the judgment of the Adviser, does not represent fair value shall each be valued as

of the measurement date using all techniques appropriate under the circumstances and for which sufficient data is available.

These valuation techniques may vary by investment and include comparable public market valuations, comparable precedent

transaction valuations and/or discounted cash flow analyses. The Adviser engages third-party valuation firms to provide

independent prices on securities/instruments. The Adviser's Valuation Committee (the "Valuation Committee") reviews the

assessments of the third-party valuation firms and provides any recommendations with respect to changes to the fair value of

each investment in the portfolio and approves the fair value of each investment in the portfolio in good faith based on the input

of the third-party valuation firms. If the Adviser reasonably believes a valuation from a pricing vendor is inaccurate or

unreliable, the Valuation Committee will consider an "override" of the particular valuation. The Valuation Committee will

consider all available information at its disposal prior to making a valuation determination.

U.S. GAAP establishes a hierarchical disclosure framework which ranks the level of observability of market price

inputs used in measuring investments at fair value. The observability of inputs is impacted by a number of factors, including the

type of investment and the characteristics specific to the investment and state of the marketplace, including the existence and

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

transparency of transactions between market participants. Investments with readily available quoted prices or for which fair

value can be measured from quoted prices in active markets generally have a higher degree of market price observability and a

lesser degree of judgment applied in determining fair value.

Investments measured and reported at fair value are classified and disclosed based on the observability of inputs used

in determination of fair values, as follows:

• Level 1— inputs to the valuation methodology are quoted prices available in active markets for identical investments

as of the reporting date. The types of financial instruments included in Level 1 generally include unrestricted

securities, including equities and derivatives, listed in active markets. The Adviser does not adjust the quoted price for

these investments, even in situations where we hold a large position and a sale could reasonably impact the quoted

price.

• Level 2—inputs to the valuation methodology are either directly or indirectly observable as of the reporting date and

are those other than quoted prices in active markets. The type of financial instruments in this category generally

includes less liquid and restricted securities listed in active markets, securities traded in other than active markets,

government and agency securities, and certain over-the-counter derivatives where the fair value is based on observable

inputs.

• Level 3—inputs to the valuation methodology are unobservable and significant to overall fair value measurement. The

inputs into the determination of fair value require significant management judgment or estimation. Financial

instruments that are included in this category generally include investments in privately held entities, non-investment

grade residual interests in securitizations, collateralized loan obligations, and certain over-the-counter derivatives

where the fair value is based on unobservable inputs.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such

cases, an investment's level within the fair value hierarchy is based on the lowest level of input that is significant to the overall

fair value measurement. The Adviser's assessment of the significance of a particular input to the fair value measurement in its

entirety requires judgment, and considers factors specific to the investment.

Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. During the

six month period ended March 31, 2026, there were no transfers.

The following table summarizes the Fund's investments measured at fair value on a recurring basis by the above fair

value hierarchy levels as of March 31, 2026:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** |
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Assets** |  | | |  |
| Cash Equivalents | $2812913 | $— | $— | $2812913 |
| Collateralized Loan Obligations |  |  | 120714556 | 120714556 |
| Real Estate |  |  | 2175000 | 2175000 |
| **Total Investments, at Fair Value** | **$2812913** | **$—** | **$122889556** | **$125702469** |

---

The changes in the Fund's investments at fair value for which the Fund has classified as Level 3 for the six month

period ended March 31, 2026, are as follows:

---

| | | | |
|:---|:---|:---|:---|
| **For the Six Months Ended March 31, 2026** | | | |
|  | **Collateralized** <br>**Loan** <br>**Obligations** | **Real Estate** | **Total** |
|  | **Collateralized** <br>**Loan** <br>**Obligations** | **Real Estate** | **Total** |
| Balance, beginning of period | $190028718 | $2175000 | $192203718 |
| Purchases of investments | 14513070 |  | 14513070 |
| Proceeds from sales and paydowns of investments <sup>(1)</sup> | (33275707) |  | (33275707) |
| Net realized gains (losses) | (12835266) |  | (12835266) |
| Accretion of discount (premium) | 332 |  | 332 |
| Net change in unrealized appreciation (depreciation) | (37716591) |  | (37716591) |
| Balance, end of period | $120714556 | $2175000 | $122889556 |
| Net change in unrealized appreciation (depreciation) included in earnings related to <br>investments still held at the reporting date<br>| $(42245835) | $— | $(42245835) |

---

(1) Includes $7,750,707 of return of capital on CLO investments from recurring cash flows and refinancings.

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

The following table summarizes the Fund's financial liabilities disclosed, but not carried at fair value as of March 31,

2026 and the level of each financial liability within the fair value hierarchy:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** |
|  | **Carrying Value** | **Fair Value** | **Level 1** | **Level 2** | **Level 3** |
| Credit Facility <sup>(1)</sup> | $8000000 | $8000000 | $— | $— | $8000000 |
| 7.125% Series B Convertible Preferred Shares <sup>(2)</sup> | 3517000 | 3360965 |  |  | 3360965 |
| 7.375% Series D Term Preferred Shares <sup>(3)</sup> | 29016726 | 30096000 | 30096000 |  |  |
| 7.25% Series E Convertible Preferred Shares <sup>(2)</sup> | 16739041 | 16368800 |  |  | 16368800 |
| **Total** | **$57272767** | **$57825765** | **$30096000** | **$—** | **$27729765** |

---

(1) The carrying value of the credit facility generally approximates its fair value due to its variable interest rates. The credit facility is

categorized as Level 3 within the hierarchy.

(2) Fair value is estimated by discounting remaining payments using current market rates, plus the fair value of the embedded conversion

option as determined using an applicable pricing model.

(3) For the Series D Term Preferred Shares, fair value is based upon the closing price on the last day of the period. The Series D Term

Preferred Shares are listed on the New York Stock Exchange (trading symbol "CCID").

The Fund generally uses the following framework when determining the fair value of investments that are categorized

as Level 3:

The fair value of CLOs is estimated based on various valuation models from third-party pricing services. Those

analyses consider the current trading activity, position size, liquidity, current financial condition of the CLOs, the third-party

financing environment, reinvestment rates, recovery lags, discount rates, and default forecasts. The Fund corroborates

quotations from pricing services either with other available pricing data and subsequent or recent trading information. These

securities are classified as Level 3.

The following table summarizes the quantitative information related to the significant unobservable inputs for Level 3

instruments which are carried at fair value as of March 31, 2026:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Fair Value as of** <br>**March 31, 2026** | **Valuation** <br>**Techniques** | **Significant** <br>**Unobservable** <br>**Inputs** | **Range** | **Range** | **Weighted**<br>**Average** |
|  | **Fair Value as of** <br>**March 31, 2026** | **Valuation** <br>**Techniques** | **Significant** <br>**Unobservable** <br>**Inputs** | **Low** | **High** | **Weighted**<br>**Average** |
| Collateralized Loan Obligations | $119416284 | Consensus Pricing | Indicative Quotes | 0.60% | 99.5% | 45.9% |
|  | $1298272 | Discounted Cash Flow | Discount Rate | 20.0% | 20.0% | 20.0% |
| Real Estate  | 2175000 | Market Approach | Bid Price | 54.4% | 54.4% | 54.4% |
| Total Level 3 Investments | $122889556 |  |  |  |  |  |

---

The significant unobservable inputs used in the fair value measurement of the Fund's investments in CLOs are

indicative quotes. Significant decreases in indicative quotes may result in a significantly lower fair value measurement. The

Fund's Real Estate investment is being valued based on an indicative bid received.

**4. RELATED PARTY TRANSACTIONS**

*Investment Advisory Agreement*

On November 28, 2022, the Fund's Board of Trustees, including a majority of the Trustees who are not "interested

persons" as that term is defined in the 1940 Act, as amended, approved the Investment Advisory Agreement, subject to

Shareholder approval. The Board weighed a number of factors in reaching its decision to approve the Investment Advisory

Agreement, including, without limitation, the history, reputation, and resources of CGCIM, prior performance results achieved

by CGCIM, and quality of services to be provided by CGCIM. The Board considered CGCIM's expertise in managing

collateralized loan obligation securities.

The Shareholders approved the Investment Advisory Agreement on June 15, 2023 and it became effective on July 14,

2023, at which time the original Investment Advisory Agreement between the Fund and Oakline Advisors, LLC terminated.

Pursuant to the Investment Advisory Agreement, by and between the Fund and the Adviser, and in consideration of the

advisory services provided by the Adviser to the Fund, the Adviser is entitled to a fee consisting of two components—a base

management fee (the "Management Fee") and an incentive fee (the "Incentive Fee").

The Management Fee is calculated and payable monthly in arrears at the annual rate of 1.75% of the month-end value

of the Fund's Managed Assets. "Managed Assets" means the total assets of the Fund (including any assets attributable to any

preferred shares or to indebtedness) minus the Fund's liabilities other than liabilities relating to indebtedness.

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

The incentive fee is calculated and payable quarterly in arrears based upon the Fund's pre-incentive fee net investment

income for the immediately preceding quarter, and is subject to a hurdle rate, expressed as a rate of return on the Fund's net

assets, equal to 2.00% per quarter (or an annualized hurdle rate of 8.00%), subject to a "catch-up" feature. For this purpose,

"pre-incentive fee net investment income" means interest income, dividend income, income generated from original issue

discounts, payment-in-kind income, and any other income earned or accrued during the calendar quarter, minus the Fund's

operating expenses (which, for this purpose shall not include any distribution and/or shareholder servicing fees, litigation, any

extraordinary expenses or Incentive Fee) for the quarter. For purposes of computing the Fund's pre-incentive fee net investment

income, the calculation methodology will look through total return swaps as if the Fund owned the referenced assets directly.

As a result, the Fund's pre-incentive fee net investment income includes net interest, if any, associated with a derivative or

swap, which is the difference between (a) the interest income and transaction fees related to the reference assets and (b) all

interest and other expenses paid by the Fund to the derivative or swap counterparty. For purposes of the Incentive Fee, net

assets are calculated for the relevant quarter as the weighted average of the net asset value of the Fund as of the first business

day of each month therein. The weighted average net asset value shall be calculated for each month by multiplying the net asset

value as of the beginning of the first business day of the month times the number of days in that month, divided by the number

of days in the applicable calendar quarter.

The Fund pays its Adviser an incentive fee with respect to its pre-incentive fee net investment income in each calendar

quarter as follows:

• No incentive fee based on pre-incentive fee net investment income in any calendar quarter in which its pre-incentive

fee net investment income does not exceed the hurdle rate of 2.00%;

• 100% of the portion of the Fund's pre-incentive fee net investment income that exceeds the hurdle rate but is less than

or equal to 2.4242% (the "catch-up") is payable to the Adviser if the Fund's pre-incentive fee net investment income,

expressed as a percentage of the Fund's net assets in respect of the relevant calendar quarter, exceeds the hurdle rate

but is less than or equal to 2.4242% (9.6968% annualized). The "catch-up" provision is intended to provide the

Adviser with an incentive fee of 17.5% on all of the Fund's pre-incentive fee net investment income when the Fund's

pre-incentive fee net investment income reaches 2.4242% of net assets; and

• 17.5% of the portion of the Fund's pre-incentive fee net investment income that exceeds the "catch-up" will be payable

to the Adviser if the Fund's pre-incentive fee net investment income, expressed as a percentage of the Fund's net

assets in respect of the relevant calendar quarter, exceeds 2.4242% (9.6968% annualized). As a result, once the hurdle

rate is reached and the catch-up is achieved, 17.5% of all the Fund's pre-incentive fee net investment income thereafter

is allocated to the Adviser.

During the six month period ended March 31, 2026, the management fee was $1,572,708 and the incentive fee related

to pre-incentive net investment income was $253,737.

As of March 31, 2026, $393,621 and $253,737 were included in management fee payable and incentive fee payable,

respectively, in the accompanying Statement of Assets and Liabilities.

*Expense Limitation Agreement*

The Adviser and the Fund entered into an Expense Limitation Agreement under which the Adviser had agreed

contractually to waive its Management Fee and/or reimburse the Fund's operating expenses on a monthly basis to the extent

that the Fund's monthly total annualized fund operating expenses (excluding (i) expenses directly related to the costs of making

investments, including interest and structuring costs for borrowings and line(s) of credit, taxes, brokerage costs, the Fund's

proportionate share of expenses related to co-investments, litigation and extraordinary expenses, (ii) Incentive Fees, expenses

related to equity or debt offerings, and (iii) expenses associated with the Transaction Agreement, including expenses related to

the liquidation as defined therein) in respect of the relevant month not to exceed 2.50% of the Fund's average daily net assets.

The Expense Limitation Agreement terminated based on its terms on August 17, 2023, which was the date that 75% of the

Fund's gross assets were invested in collateralized loan obligation equity and debt investments.

CGCIM also had a Fee Waiver Agreement under which it had agreed to irrevocably waive the portion of its

management and incentive fees on Fund managed assets invested in exchange traded funds through January 12, 2024 (the

"Termination Date"), as the Fund's portfolio transitioned to the new investment strategy. CGCIM was not entitled to recoup

any waived fees under the Fee Waiver Agreement. For the period from July 14, 2023, the date CGCIM replaced Oakline as the

Fund's new investment adviser, through the Termination Date, the Fund did not have any investments in exchange traded

funds, and thus no management or incentive fees were waived under the Fee Waiver Agreement.

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

The Adviser is obligated to pay expenses associated with providing the investment services stated in the Investment

Advisory Agreement, including compensation of and office space for its officers and employees connected with investment and

economic research, trading and investment management of the Fund.

*Board of Trustees*

The Fund's Board of Trustees currently consists of five members, three of whom are Independent Trustees. The Board

of Trustees has established an Audit Committee, a Nominating and Governance Committee and an Independent Trustees

Committee, the members of each of which consist entirely of the Fund's Independent Trustees. The Board of Trustees may

establish additional committees in the future. During the six month period ended March 31, 2026, the Fund incurred $62,329 in

fees and expenses associated with its Independent Trustees' services on the Fund's Board of Trustees and its committees. As of

March 31, 2026, no fees or expenses associated with the Fund's Independent Trustees were payable.

*Shareholder Concentration*

Related parties owned approximately 24% of the Fund's total outstanding shares as of March 31, 2026. Related parties

may include, but are not limited to, the Adviser and its affiliates, affiliated broker dealers, fund of funds, and directors or

employees.

**5. RISK FACTORS**

**Investment Risks**

*Portfolio Fair Value Risk*

Under the Investment Company Act, the Fund is required to carry its portfolio investments at market value or, if there

is no readily available market value, at fair value. There is not a public market for the CLO investments we target. As a result,

the Adviser values these securities at least quarterly, or more frequently as may be required from time to time, at fair value. The

Adviser, as valuation designee, is responsible for the valuation of the Fund's portfolio investments and implementing the

portfolio.

The Fund expects that it will hold a high proportion of Level 3 investments relative to its total investments, which is

directly related to the Fund's investment philosophy and target portfolio. The Adviser has engaged an independent valuation

firm to fair value the Fund's Level 3 investments on a monthly basis. A retained independent valuation firm will have expertise

in complex valuations associated with alternative investments and utilize a variety of techniques to calculate a security's/

instrument's valuation. The valuation approach may vary by security/instrument but may include comparable public market

valuations, comparable transaction valuations and discounted cash flow analyses. All factors that might materially impact the

value of an investment (e.g., operating results, financial condition, achievement of milestones, economic and/or market events

and recent sales prices) may be considered. The factors and methodologies used for the valuation of such securities are not

necessarily an indication of the risks associated with investing in those securities nor can it be assured that the Fund can realize

the fair value assigned to a security if it were to sell the security. Because such valuations are inherently uncertain, they often

reflect only periodic information received by the Adviser about such companies' financial condition and/or business operations,

which may be on a lagged basis and therefore fluctuate over time and can be based on estimates. Determinations of fair value

may differ materially from the values that would have been used if an exchange-traded market for these securities existed.

*Potential Conflicts of Interest Risk—Allocation of Investment Opportunities*

The Adviser has adopted allocation procedures that are intended to treat each fund they advise in a manner that, over a

period of time, is fair and equitable. The Adviser and its affiliates currently provide investment advisory and administration

services and may provide in the future similar services to other entities (collectively, "Advised Funds"). Certain existing

Advised Funds have, and future Advised Funds may have, investment objectives similar to those of the Fund, and such Advised

Funds will invest in asset classes similar to those targeted by the Fund. Certain other existing Advised Funds do not, and future

Advised Funds may not, have similar investment objectives, but such funds may from time to time invest in asset classes

similar to those targeted by the Fund. The Adviser will endeavor to allocate investment opportunities in a fair and equitable

manner, and in any event consistent with any fiduciary duties owed to the Fund and other clients and in an effort to avoid

favoring one client over another and taking into account all relevant facts and circumstances, including (without limitation): (i)

differences with respect to available capital, size of client, and remaining life of a client; (ii) differences with respect to

investment objectives or current investment strategies, including regarding: (a) current and total return requirements, (b)

emphasizing or limiting exposure to the security or type of security in question, (c) diversification, including industry or

company exposure, currency and jurisdiction, or (d) rating agency ratings; (iii) differences in risk profile at the time an

opportunity becomes available; (iv) the potential transaction and other costs of allocating an opportunity among various clients;

(v) potential conflicts of interest, including whether a client has an existing investment in the security in question or the issuer

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

of such security; (vi) the nature of the security or the transaction, including minimum investment amounts and the source of the

opportunity; (vii) current and anticipated market and general economic conditions; (viii) existing positions in a borrower/loan/

security; and (ix) prior positions in a borrower/loan/security. Nevertheless, it is possible that the Fund may not be given the

opportunity to participate in certain investments made by investment funds managed by investment managers affiliated with the

Adviser.

*Collateralized Loan Obligations*

The Fund invests in CLOs. Investments in CLO securities involve certain risks. CLOs are generally backed by an asset

or a pool of assets that serve as collateral. The Fund and other investors in CLO securities ultimately bear the credit risk of the

underlying collateral. Most CLOs are issued in multiple tranches, offering investors various maturity and credit risk

characteristics, often categorized as senior, mezzanine and subordinated/equity according to their degree of risk. If there are

defaults or the relevant collateral otherwise underperforms, scheduled payments to senior tranches of such securities take

precedence over those of junior tranches which are the focus of our investment strategy, and scheduled payments to junior

tranches have a priority in right of payment to subordinated/equity tranches. CLOs may present risks similar to those of the

other types of debt obligations and, in fact, such risks may be of greater significance in the case of CLOs. For example,

investments in junior debt and equity securities issued by CLOs, involve risks, including credit risk and market risk. Changes in

interest rates and credit quality may cause significant price fluctuations. In addition to the general risks associated with

investing in debt securities, CLO securities carry additional risks, including: (1) the possibility that distributions from collateral

assets will not be adequate to make interest or other payments; (2) the quality of the collateral may decline in value or default;

(3) investments in CLO junior debt and equity tranches will likely be subordinate in right of payment to other senior classes of

CLO debt; and (4) the complex structure of a particular security may not be fully understood at the time of investment and may

produce disputes with the issuer or unexpected investment results. Changes in the collateral held by a CLO may cause payments

on the instruments the Fund holds to be reduced, either temporarily or permanently.

*Covenant-Lite Loans Risk*

Covenant-lite loans may comprise a significant portion of the senior secured loans underlying the CLOs in which we

invest. Over the past decade, the senior secured loan market has evolved from one in which covenant-lite loans represented a

minority of the market to one in which such loans represent a significant majority of the market. Generally, covenant-lite loans

provide borrower companies more freedom to negatively impact lenders because their covenants are incurrence-based, which

means they are only tested and can only be breached following an affirmative action of the borrower, rather than by a

deterioration in the borrower's financial condition. Accordingly, to the extent that the CLOs that we invest in hold covenant-lite

loans, our CLOs may have fewer rights against a borrower and may have a greater risk of loss on such investments as compared

to investments in or exposure to loans with financial maintenance covenants.

*Subordinated Securities*

CLO equity and junior debt securities are subordinated to more senior tranches of CLO debt. CLO equity and junior

debt securities are subject to increased risks of default relative to the holders of superior priority interests in the same CLO. In

addition, at the time of issuance, CLO equity securities are under-collateralized in that the face amount of the CLO debt and

CLO equity of a CLO at inception exceed its total assets. The Fund will typically be in a subordinated or first loss position with

respect to realized losses on the underlying assets held by the CLOs in which we are invested.

*High Yield Investment Risk*

The CLO equity and junior debt securities are typically rated below investment grade, or in the case of CLO equity

securities unrated, and are therefore considered "higher yield" or "junk" securities and are considered speculative with respect

to timely payment of interest and repayment of principal. The senior secured loans and other credit-related assets underlying

CLOs are also typically higher yield investments. Investing in CLO equity and junior debt securities and other high yield

investments involves greater credit and liquidity risk than investment grade obligations, which may adversely impact the Fund's

performance.

*Default Risk*

The Fund is subject to risks associated with defaults on an underlying asset held by a CLO.

• A default and any resulting loss, as well as other losses on an underlying asset held by a CLO may reduce the

fair value of our corresponding CLO investment. A wide range of factors could adversely affect the ability of

the borrower of an underlying asset to make interest or other payments on that asset. To the extent that actual

defaults and losses on the collateral of an investment exceed the level of defaults and losses factored into its

purchase price, the value of the anticipated return from the investment will be reduced. The more deeply

subordinated the tranche of securities in which we invest, the greater the risk of loss upon a default. For

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

example, CLO equity is the most subordinated tranche within a CLO and is therefore subject to the greatest

risk of loss resulting from defaults on the CLO's collateral, whether due to bankruptcy or otherwise. Any

defaults and losses in excess of expected default rates and loss model inputs will have a negative impact on

the fair value of our investments, will reduce the cash flows that the Fund receives from its investments,

adversely affect the fair value of the Fund's assets and could adversely impact the Fund's ability to pay

dividends. Furthermore, the holders of the junior equity and debt tranches typically have limited rights with

respect to decisions made with respect to collateral following an event of default on a CLO. In some cases,

the senior most class of notes can elect to liquidate the collateral even if the expected proceeds are not

expected to be able to pay in full all classes of notes. The Fund could experience a complete loss of its

investment in such a scenario.

• In addition, the collateral of CLOs may require substantial workout negotiations or restructuring in the event

of a default or liquidation. Any such workout or restructuring is likely to lead to a substantial reduction in the

interest rate of such asset and/or a substantial write-down or write-off of all or a portion of the principal of

such asset. Any such reduction in interest rates or principal will negatively affect the fair value of the Fund's

portfolio.

*Non-Diversification Risk*

The Fund is a non-diversified investment company under the 1940 Act and expects to hold a narrower range of

investments than a diversified fund under the 1940 Act.

*Leverage Risk*

The use of leverage, whether directly or indirectly through investments such as CLO equity or junior debt securities

that inherently involve leverage, may magnify the Fund's risk of loss. CLO equity or junior debt securities are very highly

leveraged (with CLO equity securities typically being leveraged ten times), and therefore the CLO securities in which the Fund

invests are subject to a higher degree of loss since the use of leverage magnifies losses.

*Senior Management Personnel of the Adviser*

Since the Fund has no employees, it depends on the investment expertise, skill and network of business contacts of the

Adviser. The Adviser evaluates, negotiates, structures, executes, monitors and services the Fund's investments. The Fund's

future success depends to a significant extent on the continued service and coordination of the Adviser and its senior

management team. The departure of any members of the Adviser's senior management team could have a material adverse

effect on the Fund's ability to achieve its investment objective.

*Conflicts of Interest Risk*

The Fund's executive officers and trustees, other current and future principals of the Adviser and certain members of

the Adviser's investment committee may serve as officers, trustees or principals of other entities and affiliates of the Adviser

and funds managed by the Fund's affiliates that operate in the same or a related line of business as the Fund does. Currently, the

Fund's executive officers, as well as the other principals of the Adviser, manage other funds affiliated with Carlyle, including

other existing and future affiliated BDCs and registered closed-end funds, including Carlyle Secured Lending, Inc., Carlyle

Credit Solutions, Inc. and Carlyle Tactical Private Credit Fund. In addition, the Adviser's investment team has responsibilities

for sourcing and managing private debt investments for certain other investment funds and accounts. Accordingly, they have

obligations to investors in those entities, the fulfillment of which may not be in the best interests of, or may be adverse to the

interests of, the Fund and its Shareholders. Although the professional staff of the Adviser will devote as much time to

management of the Fund as appropriate to enable the Adviser to perform its duties in accordance with the Investment Advisory

Agreement, the investment professionals of the Adviser may have conflicts in allocating their time and services among the

Fund, on the one hand, and investment vehicles managed by Carlyle or one or more of its affiliates on the other hand.

*Liquidity Risk*

Generally, there is no public market for the CLO investments the Fund targets. As such, the Fund may not be able to

sell such investments quickly, or at all. If the Fund is able to sell such investments, the prices the Fund receives may not reflect

the Adviser's assessment of their fair value or the amount paid for such investments by the Fund.

*The Adviser's Incentive Fee Risk*

The Investment Advisory Agreement entitles the Adviser to receive incentive compensation on income regardless of

any capital losses. In such case, the Fund may be required to pay the Adviser incentive compensation for a fiscal quarter even if

there is a decline in the value of the Fund's portfolio or if the Fund incurs a net loss for that quarter. Any Incentive Fee payable

by the Fund that relates to its net investment income may be computed and paid on income that may include interest that has

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

been accrued but not yet received. If an investment defaults on a loan that is structured to provide accrued interest, it is possible

that accrued interest previously included in the calculation of the Incentive Fee will become uncollectible. The Adviser is not

under any obligation to reimburse the Fund for any part of the Incentive Fee it received that was based on accrued income that

the Fund never received as a result of a default by an entity on the obligation that resulted in the accrual of such income, and

such circumstances would result in the Fund's paying an Incentive Fee on income it never received. The Incentive Fee payable

by the Fund to the Adviser may create an incentive for it to make investments on the Fund's behalf that are risky or more

speculative than would be the case in the absence of such compensation arrangement. The way in which the Incentive Fee

payable to the Adviser is determined may encourage it to use leverage to increase the return on the Fund's investments. In

addition, the fact that the Management Fee is payable based upon the Fund's Managed Assets, which would include any

borrowings for investment purposes, may encourage the Adviser to use leverage to make additional investments. Under certain

circumstances, the use of leverage may increase the likelihood of default, which would disfavor Shareholders. Such a practice

could result in the Fund's investing in more speculative securities than would otherwise be in its best interests, which could

result in higher investment losses, particularly during cyclical economic downturns.

**Market Risks**

The success of the Fund's activities will be affected by general economic and market conditions, such as interest rates,

availability of credit, credit defaults, inflation rates, economic uncertainty, changes in laws (including laws relating to taxation

of the Fund's investments), trade barriers and tariffs, currency exchange controls, disease outbreaks, pandemics, and national

and international political, environmental and socioeconomic circumstances (including wars, terrorist acts or security

operations). In addition, the current U.S. political environment and the resulting uncertainties regarding actual and potential

shifts in U.S. foreign investment, trade, taxation, economic, environmental and other policies under the current Administration,

as well as the impact of geopolitical tension, such as a deterioration in the bilateral relationship between the U.S. and China or

an escalation in conflict in the Middle East or between Russia and Ukraine, could lead to disruption, instability and volatility in

the global markets. It is not possible to predict the duration or extent of longer-term consequences of these conflicts, which

could include further sanctions, retaliatory and escalating measures, embargoes, regional instability, geopolitical shifts and

adverse effects on or involving macroeconomic conditions, the energy sector, supply chains, inflation, security conditions,

currency exchange rates and financial markets around the globe. Any such market disruptions could have a material adverse

effect on our business, financial condition and results of operations. Unfavorable economic conditions also would be expected

to increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us.

Current and historic market turmoil has illustrated that market environments may, at any time, be characterized by

uncertainty, volatility and instability. For example, the outbreak of COVID-19 caused materially reduced consumer demand and

economic output, disrupting supply chains, resulting in market closures, travel restrictions and quarantines, and adversely

impacting local and global economies. As with other serious economic disruptions, governmental authorities and regulators are

responding to this crisis with significant fiscal and monetary policy changes, including by providing direct capital infusions into

companies, introducing new monetary programs and considerably lowering interest rates, which, in some cases resulted in

negative interest rates.

*Inflation Risk*

Inflation risk is the risk that the value of certain assets or income from the Fund's investments will be worth less in the

future as inflation decreases the value of money. As inflation increases, the real value of investments and distributions can

decline. In addition, during any periods of rising inflation, the dividend rates or borrowing costs associated with the Fund's use

of leverage would likely increase, which would tend to further reduce returns to shareholders.

*Interest Rate Risk*

The senior secured loans underlying the CLOs in which the Fund invests typically have floating interest rates. A

fluctuating interest rate environment may increase loan defaults, resulting in losses for the CLOs in which the Fund invests. In

addition, fluctuating interest rates may lead to higher prepayment rates, as corporate borrowers look to avoid escalating interest

payments or refinance floating rate loans. Further, a general rise in interest rates will increase the financing costs of the CLOs.

However, since many of the senior secured loans within these CLOs have Benchmark floors, if the Benchmark is below the

applicable Benchmark floor, there may not be corresponding increases in investment income which could result in the CLO not

having adequate cash to make interest or other payments on the securities which the Fund holds.

*Regulatory Risk*

Government regulation and/or intervention may change the way the Fund is regulated, affect the expenses incurred

directly by the Fund, affect the value of its investments and limit the Fund's ability to achieve its investment objective.

Government regulation may change frequently and may have significant adverse consequences. Moreover, government

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

regulation may have unpredictable and unintended effects. In addition to exposing the Fund to potential new costs and

expenses, additional regulation or changes to existing regulation may also require changes to the Fund's investment practices.

*Credit Risk*

Credit risk relates to the ability of the borrower under an instrument to make interest and principal payments as they

become due. If (1) a CLO in which the Fund invests, (2) an underlying asset of any such CLO or (3) any other type of credit

investment in the Fund's portfolio declines in price or fails to pay interest or principal when due because the issuer or debtor, as

the case may be, experiences a decline in its financial status, our income, NAV and/or market price would be adversely

impacted.

*Credit Spread Risk*

Credit spread risk is the risk that credit spreads (i.e., the difference in yield between securities that is due to differences

in their credit quality) may increase when the market expects below-investment-grade bonds to default more frequently.

Widening credit spreads may quickly reduce the market values of below-investment-grade and unrated securities. In recent

years, the U.S. capital markets experienced extreme volatility and disruption following the spread of COVID-19, which

increased the spread between yields realized on risk-free and higher risk securities, resulting in illiquidity in parts of the capital

markets. Central banks and governments played a key role in reintroducing liquidity to parts of the capital markets. Future exits

of these financial institutions from the market may reintroduce temporary illiquidity. These and future market disruptions and/

or illiquidity would be expected to have an adverse effect on the Fund's business, financial condition, results of operations and

cash flows.

*Prepayment Risk* 

The assets underlying the CLO securities are subject to prepayment by the underlying corporate borrowers. In

addition, the CLO securities and related investments are subject to prepayment risk. If the Fund or a CLO collateral manager is

unable to reinvest prepaid amounts in a new investment with an expected rate of return at least equal to that of the investment

repaid, the Fund's investment performance will be adversely impacted.

*Volatility Risk*

Volatility risk refers to the magnitude of the movement, but not the direction of the movement, in a financial

instrument's price over a defined time period. Large increases or decreases in a financial instrument's price over a relative time

period typically indicate greater volatility risk, while small increases or decreases in its price typically indicate lower volatility

risk.

*Equity Risk*

Equity risk relates to the change in value of equity securities as they relate to increases or decreases in the general

market.

*Foreign Exchange Rate Risk*

Foreign exchange rate risk relates to the change in the U.S. dollar value of a security held that is denominated in a

foreign currency. The U.S. dollar value of a foreign currency denominated security will decrease as the dollar appreciates

against the currency, while the U.S. dollar value will increase as the dollar depreciates against the currency.

*Cybersecurity Risk*

Cybersecurity incidents and cyber-attacks have been occurring globally at a more frequent and severe level and will

likely continue to increase in frequency in the future. The Adviser faces various security threats on a regular basis, including

ongoing cyber security threats to and attacks on its information technology infrastructure that are intended to gain access to its

proprietary information, destroy data or disable, degrade or sabotage its systems. These security threats could originate from a

wide variety of sources, including unknown third parties outside of the Adviser. Although the Adviser is not currently aware

that it has been subject to cyber-attacks or other cyber incidents which, individually or in the aggregate, have materially affected

its operations or financial condition, there can be no assurance that the various procedures and controls utilized to mitigate these

threats will be sufficient to prevent disruptions to its systems.

**6. BORROWINGS**

In accordance with the Investment Company Act, the Fund is currently only allowed to borrow amounts such that its

asset coverage, as defined in the Investment Company Act, is 300% or more for leverage obtained through debt or 200% or

more for leverage obtained through preferred shares. As of March 31, 2026, asset coverage (exclusive of preferred shares) was

1,623% and asset coverage (inclusive of preferred shares) was 220%.

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

*Credit Facility*

On July 11, 2025, the Fund entered into a revolving credit and security agreement (the "Credit Facility"). The Credit

Facility provides for maximum borrowings up to $30 million and includes an uncommitted accordion feature that permits

increases up to $50 million, subject to lender consent and other conditions.

The Credit Facility has an initial stated maturity of 36 months from the closing date, with the option for the Fund to

extend such maturity on up to two occasions for additional one-year terms, subject to certain conditions. Proceeds of the facility

may be used for general corporate purposes, including investment activities and working capital needs, subject to compliance

with the asset coverage requirements under the Investment Company Act of 1940.

Borrowings under the Credit Facility bear interest, at the Fund's election, at either (i) Term SOFR plus 3.25%, or (ii)

the Prime Rate plus 3.25%. The facility includes customary financial and restrictive covenants, including leverage, asset

coverage, and liquidity requirements, as well as restrictions on incurrence of additional debt and liens. As of March 31, 2026,

the Fund was in compliance with all covenants and other requirements under the Credit Facility. The obligations under the

Credit Facility are secured by a first priority lien on substantially all of the Fund's portfolio investments, subject to customary

exceptions.

The Credit Facility consisted of the following as of March 31, 2026:

---

| | | | |
|:---|:---|:---|:---|
|  | **Total Facility** | **Borrowings**<br>**Outstanding**<br>| **Amount**<br>**Available** <sup>(1)</sup><br>|
| Credit Facility | $30000000 | $8000000 | $22000000 |

---

(1) The Amount Available for borrowing is the Total Facility less Borrowings Outstanding, and is subject to compliance with applicable covenants and

financial ratios.

For the six month period ended March 31, 2026, $90,966 of interest expense related to the Credit Facility was

included in interest expense on the Statement of Operations. Costs incurred in connection with the closing of the Credit

Facility are being amortized to interest expense over the term of the Credit Facility. For the six month period ended March

31, 2026, the Fund recorded $122,376 of amortization of deferred issuance costs related to the Credit Facility.

**7. PREFERRED SHARES**

**8.75% Series A Term Preferred Shares**

On October 24, 2023, the Fund issued 1,200,000 shares of 8.75% Series A Term Preferred Shares due October 31,

2028, for aggregate gross proceeds of $30,000,000. On November 6, 2023, pursuant to the overallotment option granted to the

Underwriters in the Underwriting Agreement, dated October 18, 2023, the Fund issued 80,000 additional shares for gross

proceeds of $2,000,000. On November 30, 2023, the Fund issued an additional 800,000 shares for gross proceeds of

$20,000,000. The shares are listed on the New York Stock Exchange under the symbol "CCIA". On November 3, 2025 (the

"Redemption Date"), the Fund redeemed all of the outstanding 8.75% Series A Term Preferred Shares. The following table

summarizes the details of the Fund's Series A Term Preferred Shares:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Initial Issuance** <br>**Date**<br>| **Redemption** <br>**Date**<br>| **Dividend** <br>**Rate**<br>| **Share** <br>**Amount**<br>| **Price Per** <br>**share**<br>| **Total Raise** |
| Series A Term <br>Preferred Shares<br>| 10/24/2023 | 11/3/2025 | 8.75% | 2080000 | $25.00 | $52000000 |

---

The redemption price of the Series A Term Preferred Shares was $25 per share, plus an amount equal to all unpaid

dividends and distributions on each share accumulated to (but excluding) the Redemption Date.

The holders of Series A Term Preferred Shares were entitled to receive monthly dividends at a fixed annual rate of

8.75% of the Series A Liquidation Preference ($2.1875 per share per year), or the dividend rate. Cumulative cash dividends on

each share of Series A Term Preferred Shares accumulated from and included the original issue date. Dividends on the Series A

Term Preferred Shares were accrued daily, payable monthly in arrears, and included in Interest expense on the Statement of

Operations. For the six month period ended March 31, 2026, $404,560 of dividend expense related to the Series A Term

Preferred Shares was included in interest expense on the Statement of Operations. Costs incurred in connection with the

issuance of the Series A Term Preferred Shares were amortized to interest expense over the term of the Series A Term Preferred

Shares. For the six month period ended March 31, 2026, the Fund recorded $1,354,722 of amortization of deferred issuance

costs related to the Series A Term Preferred Shares.

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

**7.125% Series B Convertible Preferred Shares**

On August 27, 2024, the Fund issued 11,517 shares of 7.125% Series B Convertible Preferred Shares due August 27,

2029, in a private placement for aggregate gross proceeds of $11,517,000. The Series B Convertible Preferred Shares have a

liquidation preference of $1,000.00 per share (the "Series B Liquidation Preference"), and pay a quarterly dividend at a fixed

annual rate of 7.125% of the Series B Liquidation Preference, or $71.25 per share, per year. The Series B Convertible Preferred

Shares rank senior to the common shares in priority of payment of dividends and as to the distribution of assets upon

dissolution, liquidation, or winding up of the Fund's affairs. The Series B Convertible Preferred Shares rank equal in priority

with the Fund's Series D Term Preferred Shares, and Series E Convertible Preferred Shares. The following table summarizes

the details of the Fund's Series B Convertible Preferred Shares:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Initial Issuance** <br>**Date**<br>| **Redemption** <br>**Date**<br>| **Dividend** <br>**Rate**<br>| **Share** <br>**Amount**<br>| **Price Per** <br>**share**<br>| **Total Raise** |
| Series B Convertible <br>Preferred Shares<br>| 8/27/2024 | 8/27/2029 | 7.125% | 11517 | $1000.00 | $11517000 |

---

At any time on or after February 27, 2025, at the Fund's sole option, the Fund may redeem, from time to time, the

outstanding Series B Convertible Preferred Shares in whole or in part, at a price per share equal to the sum of the Series B

Liquidation Preference plus an amount equal to accumulated but unpaid dividends, if any, on such shares. The Fund is required

to redeem, all outstanding Series B Convertible Preferred Shares on August 27, 2029 (the "Series B Term Redemption Date"),

at a redemption price equal to the Series B Liquidation Preference plus an amount equal to accumulated but unpaid dividends, if

any, to the date of redemption. The Fund cannot effect any amendment, alteration or repeal its obligation to redeem all of the

Series B Convertible Preferred Shares on the Series B Term Redemption Date without the prior, unanimous approval of the

holders of the Series B Convertible Preferred Shares.

Shareholders of the Series B Convertible Preferred Shares may opt to convert the shares at any time on or after the

date six months after the issuance of the Series B Convertible Preferred Share into common shares equal to the Series B

Liquidation Preference of the Series B Convertible Preferred Shares, plus an amount equal to accumulated but unpaid

dividends, if any, divided by the Conversion Price. The "Series B Conversion Price" is the greater of (i) the market price per

common share, represented by the average official closing price for the five trading days immediately prior to the date of

exercise, or (ii) the Fund's most recently reported net asset value per common share immediately prior to the date of exercise. If

the Fund fails to fulfill its obligations to deliver common shares upon conversion, the quarterly dividend rate payable on the

Series B Convertible Preferred Shares will increase to a fixed annual rate of 9.125% of the Series B Liquidation Preference until

the date on which the Fund fulfills its delivery obligations. No holder of Series B Convertible Preferred Shares may exercise its

conversion right if upon conversion the holder would receive common Shares that would cause funds and accounts managed by

the investment adviser to such funds and account and any person controlled by the parent company of such investment adviser

to beneficially own in the aggregate more than 4.9% of the common Shares. In addition, notwithstanding anything in the Fund's

Declaration of Trust to the contrary, no holder of Series B Convertible Preferred Shares that is an investment company (as

defined in the 1940 Act) or would be an investment company but for Section 3(c)(1) or 3(c)(7) of the 1940 Act may exercise its

conversion privilege or be entitled to receive common Shares upon the exercise of its conversion privilege, to the extent (but

only to the extent) that the receipt of such common Shares would cause such holder to become, directly or indirectly, a

beneficial owner of more than 3% of the Fund's outstanding voting securities.

For the six month period ended March 31, 2026, $125,285 of dividend expense related to the Series B Convertible

Preferred Shares was included in interest expense in the Statement of Operations. Costs incurred in connection with the

issuance of the Series B Convertible Preferred Shares were amortized to interest expense over the 12 months period following

the initial issuance date.

The Series B Convertible Preferred Shares were recorded net of unamortized deferred issuance costs and included as

a liability on the Statement of Assets and Liabilities. The carrying value of the Series B Convertible Preferred Shares is

$3,517,000. As of March 31, 2026, 8,000 shares have been converted into common shares of the Fund. The Fund's Series B

Convertible Preferred Shares balance as of March 31, 2026, was as follows:

---

| | |
|:---|:---|
|  | **As of March 31, 2026** |
| Series B Liquidation Preference | $3517000 |
| Less: Unamortized deferred issuance costs<sup>(1)</sup> |  |
| Carrying value | $3517000 |
| Fair value | $3360965 |
| Fair value price per share | $955.63 |

---

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

(1) As of March 31, 2026, the deferred issuance costs related to the Series B Convertible Preferred Shares were fully amortized.

**7.50% Series C Convertible Preferred Shares**

On January 31, 2025, the Fund issued 20,000 shares of 7.50% Series C Convertible Preferred Shares due January 31,

2030, in a private placement for aggregate net proceeds (before expenses) of approximately $18,600,000. The Series C

Convertible Preferred Shares had a liquidation preference of $1,000.00 per share (the "Series C Liquidation Preference"), and

paid a quarterly dividend at a fixed annual rate of 7.50% of the Series C Liquidation Preference, or $75.00 per share, per year.

The Series C Convertible Preferred Shares ranked senior to the common shares in priority of payment of dividends and as to the

distribution of assets upon dissolution, liquidation, or winding up of the Fund's affairs. The Series C Convertible Preferred

Shares ranked equal in priority with the Fund's Series A Term Preferred Shares, Series B Convertible Preferred Shares, Series

D Term Preferred Shares, and Series E Convertible Preferred Shares. On March 30, 2026 (the "Redemption Date"), the Fund

redeemed all of the outstanding 7.50% Series C Convertible Preferred Shares. The following table summarizes the details of the

Fund's Series C Convertible Preferred Shares:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Initial Issuance** <br>**Date**<br>| **Redemption** <br>**Date**<br>| **Dividend** <br>**Rate**<br>| **Share** <br>**Amount**<br>| **Price Per** <br>**share**<br>| **Total Raise** |
| Series C Convertible <br>Preferred Shares<br>| 1/31/2025 | 3/30/2026 | 7.50% | 20000 | $1000.00 | $20000000 |

---

The redemption price of the Series C Convertible Preferred Shares was $1,000 per share, plus an amount equal to all

unpaid dividends and distributions on each share accumulated to (but excluding) the Redemption Date.

For the six month period ended March 31, 2026, $747,193 of dividend expense related to the Series C Convertible

Preferred Shares was included in interest expense in the Statement of Operations. Costs incurred in connection with the

issuance of the Series C Convertible Preferred Shares were amortized to interest expense over the shorter of 12 months or the

period the shares were outstanding. For the six month period ended March 31, 2026, the Fund recorded $513,838 of

amortization of deferred issuance costs related to the Series C Convertible Preferred Shares.

**7.375% Series D Term Preferred Shares**

On October 30, 2025, the Fund issued 1,200,000 shares of 7.375% Series D Term Preferred Shares (the "Series D

Term Preferred Shares") due October 30, 2028, for aggregate gross proceeds of $30,000,000. The shares are listed on the New

York Stock Exchange under the symbol "CCID". The Series D Term Preferred Shares rank equal in priority with the Fund's

Series B Convertible Preferred Shares, and Series E Convertible Preferred Shares. The following table summarizes the details

of the Fund's Series D Term Preferred Shares:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Initial Issuance** <br>**Date**<br>| **Redemption** <br>**Date**<br>| **Dividend** <br>**Rate**<br>| **Share** <br>**Amount**<br>| **Price Per** <br>**share**<br>| **Total Raise** |
| Series D Term <br>Preferred Shares<br>| 10/30/2025 | 10/30/2028 | 7.375% | 1200000 | $25.00 | $30000000 |

---

Each holder of Series D Term Preferred Shares is entitled to a liquidation preference of $25.00 per share (the "Series D

Liquidation Preference"), plus an amount equal to accumulated but unpaid dividends, if any, on such shares (whether or not

earned or declared, but excluding interest on such dividends) to, but excluding, the date fixed for such redemption. The Fund is

required to redeem all outstanding shares of the Series D Term Preferred Shares on October 30, 2028 (the "Series D Mandatory

Redemption Date"), at a redemption price equal to the Series D Liquidation Preference plus an amount equal to accumulated

but unpaid dividends, if any, to the date of redemption. The Fund cannot effect any modification of or repeal its obligation to

redeem the Series D Term Preferred Shares on the Series D Mandatory Redemption Date without the prior, unanimous approval

of the holders of the Series D Term Preferred Shares. At any time on or after October 30, 2026, (the "Optional Redemption

Date"), the Fund may, at its sole option, redeem the outstanding Series D Term Preferred Shares in whole or, from time to time,

in part, at the Series D Liquidation Preference plus an amount equal to accumulated but unpaid dividends, if any, on such

shares.

The holders of Series D Term Preferred Shares are entitled to receive monthly dividends at a fixed annual rate of

7.375% of the Series D Liquidation Preference ($1.84375 per share per year), or the dividend rate. Cumulative cash dividends

on each share of Series D Term Preferred Shares accumulate from, and including, the original issue date. Dividends on the

Series D Term Preferred Shares were accrued daily, payable monthly in arrears, and included in Interest expense on the

Statement of Operations.

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

For the six month period ended March 31, 2026, $927,801 of dividend expense related to the Series D Term Preferred

Shares was included in interest expense on the Statement of Operations. Costs incurred in connection with the issuance of the

Series D Term Preferred Shares were amortized to interest expense over the term of the Series D Term Preferred Shares. For the

six month period ended March 31, 2026, the Fund recorded $152,669 of amortization of deferred issuance costs related to the

Series D Term Preferred Shares.

The Series D Term Preferred Shares are recorded net of unamortized deferred issuance costs and included as a

liability on the Statement of Assets and Liabilities. The carrying value of the Series D Term Preferred Shares is $29,016,726.

The Fund's Series D Term Preferred Shares balances as of March 31, 2026, were as follows:

---

| | |
|:---|:---|
|  | **As of March 31, 2026** |
| Series D Liquidation Preference | $30000000 |
| Less: Unamortized deferred issuance costs | 983274 |
| Carrying value | $29016726 |
| Fair value<sup>(1)</sup> | $30096000 |
| Fair value price per share<sup>(1)</sup> | $25.08 |

---

(1) Represents the March 31, 2026 closing market price per share of the Series D Term Preferred Shares on the New York Stock

Exchange.

**7.25% Series E Convertible Preferred Shares**

On October 30, 2025, the Fund issued 17,500 shares of 7.25% Series E Convertible Preferred Shares due October 30,

2030, in a private placement for aggregate net proceeds (before expenses) of approximately $16,275,000. The Series E

Convertible Preferred Shares have a liquidation preference of $1,000.00 per share (the "Series E Liquidation Preference"), and

pay a quarterly dividend at a fixed annual rate of 7.25% of the liquidation preference, or $72.50 per share, per year. The Series

E Convertible Preferred Shares rank senior to the common shares in priority of payment of dividends and as to the distribution

of assets upon dissolution, liquidation, or winding up of the Fund's affairs. The Series E Convertible Preferred Shares rank

equal in priority with the Fund's Series B Convertible Preferred Shares, and Series D Term Preferred Shares. The following

table summarizes the details of the Fund's Series E Convertible Preferred Shares:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Initial Issuance** <br>**Date**<br>| **Redemption** <br>**Date**<br>| **Dividend** <br>**Rate**<br>| **Share** <br>**Amount**<br>| **Price Per** <br>**share**<br>| **Total Raise** |
| Series E Convertible <br>Preferred Shares<br>| 10/30/2025 | 10/30/2030 | 7.25% | 17500 | $1000.00 | $17500000 |

---

At any time on or after May 1, 2026, at the Fund's sole option, the Fund may redeem, from time to time, the

outstanding Series E Convertible Preferred Shares in whole or in part, at a price per share equal to the sum of the Series E

Liquidation Preference plus an amount equal to accumulated but unpaid dividends, if any, on such shares. The Fund is required

to redeem, all outstanding Series E Convertible Preferred Shares on October 30, 2030 (the "Series E Term Redemption Date"),

at a redemption price equal to the Series E Liquidation Preference plus an amount equal to accumulated but unpaid dividends, if

any, to the date of redemption. The Fund cannot effect any amendment, alteration or repeal its obligation to redeem all of the

Series E Convertible Preferred Shares on the Series E Term Redemption Date without the prior, unanimous approval of the

holders of the Series E Convertible Preferred Shares.

Shareholders of the Series E Convertible Preferred Shares may opt to convert the shares at any time on or after the date

six months after the issuance of the Series E Convertible Preferred Shares into common shares equal to the Series E Liquidation

Preference of the Series E Convertible Preferred Shares, plus an amount equal to accumulated but unpaid dividends, if any,

divided by the Series E Conversion Price. The "Series E Conversion Price" is the greater of (i) the market price per common

share, represented by the average official closing price for the five trading days immediately prior to the date of exercise, or (ii)

the Fund's most recently reported net asset value per common share immediately prior to the date of exercise. If the Fund fails

to fulfill its obligations to deliver common shares upon conversion, the quarterly dividend rate payable on the Series E

Convertible Preferred Shares will increase to a fixed annual rate of 9.25% of the liquidation preference until the date on which

the Fund fulfills its delivery obligations. No holder of the Series E Convertible Preferred Shares may exercise its conversion

right if upon conversion the holder would receive common Shares that would cause funds and accounts managed by the

investment adviser to such funds and account and any person controlled by the parent company of such investment adviser to

beneficially own in the aggregate more than 4.9% of the common Shares. In addition, notwithstanding anything in the Fund's

Declaration of Trust to the contrary, no holder of Series E Convertible Preferred Shares that is an investment company (as

defined in the 1940 Act) or would be an investment company but for Section 3(c)(1) or 3(c)(7) of the 1940 Act may exercise its

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

conversion privilege or be entitled to receive common Shares upon the exercise of its conversion privilege, to the extent (but

only to the extent) that the receipt of such common Shares would cause such holder to become, directly or indirectly, a

beneficial owner of more than 3% of the Fund's outstanding voting securities.

For the six month period ended March 31, 2026, $527,458 of dividend expense related to the Series E Convertible

Preferred Shares was included in interest expense in the Statement of Operations. Costs incurred in connection with the

issuance of the Series E Convertible Preferred Shares were amortized to interest expense over the shorter of 12 months or the

period the shares are outstanding. For the six month period ended March 31, 2026, the Fund recorded $573,000 of amortization

of deferred issuance costs related to the Series E Convertible Preferred Shares.

The Series E Convertible Preferred Shares are recorded net of unamortized deferred issuance costs and included as a

liability on the Statement of Assets and Liabilities. The carrying value of the Series E Convertible Preferred Shares is

$16,739,041. The Fund's Series E Convertible Preferred Shares balance as of March 31, 2026, was as follows:

---

| | |
|:---|:---|
|  | **As of March 31, 2026** |
| Series E Liquidation Preference | $17500000 |
| Less: Unamortized deferred issuance costs | 760959 |
| Carrying value | $16739041 |
| Fair value  | $16368800 |
| Fair value price per share  | $935.36 |

---

Except where otherwise stated in the 1940 Act or the Fund's Declaration of Trust, each holder of Series B

Convertible Preferred Shares, Series D Term Preferred Shares, and Series E Convertible Preferred Shares will be entitled to

one vote for each share of preferred shares held on each matter submitted to a vote of the Fund's shareholders. The Fund's

preferred shareholders and common shareholders will vote together as a single class on all matters submitted to the Fund's

shareholders. Additionally, the Fund's preferred shareholders will have the right to elect two Preferred Trustees at all times,

while the Fund's preferred shareholders and common shareholders, voting together as a single class, will elect the remaining

members of the Board.

The following table details the Fund's sources of leverage as of March 31, 2026:

---

| | |
|:---|:---|
|  | **Outstanding Principal** <br>**Balance as of**<br>**March 31, 2026** |
| Borrowings |  |
| Credit Facility | $8000000 |
| Preferred Shares |  |
| Series B Convertible Preferred Shares | 3517000 |
| Series D Term Preferred Shares | 30000000 |
| Series E Convertible Preferred Shares | 17500000 |
| **Total** | **$59017000** |
| **Weighted average interest rate** | **7.27%** |

---

**8. COMMITMENTS AND CONTINGENCIES**

The Fund is not currently subject to any material legal proceedings. From time to time, the Fund may be a party to

certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of the Fund's

rights under contracts with its portfolio companies. While the outcomes of these legal proceedings, if any, cannot be predicted

with certainty, the Fund does not expect that these proceedings will have a material effect upon its financial condition or results

of operations.

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

**9. CAPITAL**

The Fund has an unlimited amount of common shares, no par value, authorized and 21,198,622 issued and

outstanding. There was no change in the Fund's amount of common shares for the six month period ended March 31, 2026.

*At-The-Market ("ATM") Program*

On October 4, 2023, the Fund entered into an Equity Distribution Agreement, as amended on May 20, 2024,

November 21, 2024, and May 21, 2025, with Ladenburg Thalmann & Co. Inc., B. Riley Securities, Inc., Oppenheimer & Co.

Inc., and Lucid Capital Markets, LLC (the "Placement Agents"). The Equity Distribution Agreement originally allowed for the

offer and sale of up to $75,000,000 in aggregate amount of the Fund's common shares, through the Placement Agents, through

an ATM offering, as defined in Rule 415 under the Securities Act of 1933. As of the amendment on May 21, 2025, the Fund

increased the maximum aggregate amount of common shares to be sold through the ATM program from $75,000,000 to

$125,000,000. The minimum price on any day at which common shares may be sold will not be below the current net asset

value of such common shares. The Fund did not sell any common shares pursuant to the ATM program for the six month period

ended March 31, 2026.

*Registered Direct Placement of Common Shares*

On August 26, 2024, the Fund entered into a purchase agreement for the purchase and sale of common shares in a

registered direct placement pursuant to the Fund's effective shelf registration filed with the SEC. On August 27, 2024, the Fund

sold 1,444,865 common shares and received approximately $11.5 million in proceeds before expenses. The offering, which was

accretive to shareholders, was executed at a price above the Fund's NAV per common share.

**10. SEGMENT REPORTING**

The Fund operates through a single operating and reporting segment and its primary investment objective is to

generate current income, with a secondary objective to generate capital appreciation. The chief operating decision maker

("CODM") is the Fund's Principal Executive Officer. The CODM assesses the performance of the Fund and makes operating

decisions, primarily based on the Fund's net asset value, net investment income and increase/decrease in net assets resulting

from operations. These performance measures also aid the CODM in determining the amount of dividends to be distributed to

the Fund's shareholders, implementing investment policy decisions, strategic initiatives, and managing and assessing the

Fund's portfolio. As the Fund's operations comprise of a single reporting segment, the segment assets are reflected on the

accompanying Statement of Assets and Liabilities as total assets and the significant segment expenses are listed on the

accompanying Statement of Operations.

**11. TAX**

The Fund has not recorded a liability for any uncertain tax positions pursuant to the provisions of ASC 740, *Income* 

*Taxes,* as of March 31, 2026.

In the normal course of business, the Fund is subject to examination by federal and certain state, local and foreign tax

regulators. The Fund's federal tax returns are generally subject to examination by the Internal Revenue Service for a period of

three years after they are filed.

The Fund's taxable income for each period is an estimate and will not be finally determined until the Fund files its tax

return for each year. Therefore, the final taxable income, and the taxable income earned in each period and carried forward for

distribution in the following period, may be different than this estimate. For the six month period ended March 31, 2026, the

Fund made distributions of $12,401,194, in which the final tax character of income will be determined at year end.

The aggregate cost of securities and other investments and the composition of unrealized appreciation and depreciation

of securities and other investments for federal income tax purposes at period end are noted in the following table.

---

| | |
|:---|:---|
|  | **Six Months Ended March** <br>**31, 2026**<br>|
| Federal tax cost of securities | $154527132 |
| Gross unrealized appreciation | 20138679 |
| Gross unrealized depreciation | (51776255) |
| Net unrealized appreciation (depreciation) | $(31637576) |

---

**CARLYLE CREDIT INCOME FUND**

**NOTES TO FINANCIAL STATEMENTS (Continued)**

**12. SUBSEQUENT EVENTS**

On April 30, 2026, the Fund paid a monthly dividend of $0.06 per common share to holders of record on April 20,

2026. Additionally, on May 19, 2026, the Fund declared dividends of $0.06 per common share, payable on each of June 30,

2026, July 31, 2026, and August 31, 2026, to holders of record as of June 17, 2026, July 21, 2026, and August 19, 2026,

respectively.

On April 30, 2026, the Fund paid a quarterly dividend of $17.8125 per share on its 7.125% Series B Convertible

Preferred Shares to holders of record on April 20, 2026.

On April 30, 2026, the Fund paid a monthly dividend of $0.1536 per share on its 7.375% Series D Term Preferred

Shares to holders of record on April 20, 2026. Additionally, on May 19, 2026, the Fund declared dividends of $0.1536 per share

on its 7.375% Series D Term Preferred Shares, payable on each of June 30, 2026, July 31, 2026, and August 31, 2026, to

holders of record as of June 17, 2026, July 21, 2026, and August 19, 2026, respectively.

On April 30, 2026, the Fund paid a quarterly dividend of $18.125 per share on its 7.25% Series E Convertible

Preferred Shares to holders of record on April 20, 2026.

On April 30, 2026, 500 shares of the 7.125% Series B Convertible Preferred Shares were converted into common

shares of the Fund.

The Fund evaluated subsequent events through the date the financial statements were issued and noted no other events

that require recognition or disclosure in the financial statements.

**DIVIDEND REINVESTMENT PLAN**

The Fund operates under the DRP administered by Equiniti. Pursuant to the DRP, the Fund's Distributions (as defined

below), net of any applicable U.S. withholding tax, are reinvested in the same class of shares of the Fund.

Shareholders automatically participate in the DRP, unless and until an election is made to withdraw from the plan on

behalf of such participating Shareholder. A Shareholder who does not wish to have Distributions automatically reinvested may

terminate participation in the DRP by written instructions to that effect to Equiniti. Shareholders who elect not to participate in

the DRP will receive all distributions in cash paid to the Shareholder of record (or, if the shares are held in street or other

nominee name, then to such nominee). Such written instructions must be received by Equiniti within 15 days prior to the

applicable dividend payment date, or the Shareholder will receive such Distribution in shares through the DRP. Under the DRP,

the Fund's Distributions to Shareholders are automatically reinvested in full and fractional shares as described below.

When the Fund declares a dividend, capital gain or other distribution (each, a "Distribution" and collectively,

"Distributions") Equiniti, on the Shareholder's behalf, will receive additional authorized shares from the Fund either newly

issued or repurchased from Shareholders by the Fund and held as treasury stock. Distributions that are reinvested through the

issuance of new shares increase our Shareholders' equity on which a management fee is payable to the Adviser. The number of

shares to be received when Distributions are reinvested will be determined by dividing the amount of the Distribution by the

lesser of (1) 95% of the market price per share of the Fund's common stock at the close of regular trading on the NYSE or (2)

the NAV per share. The newly issued shares would be issued whether our shares are trading at a premium or discount to NAV.

However, the Fund reserves the right to purchase shares in the open market in connection with the implementation of the DRP

to the extent that shares are trading at a price below NAV per share. Shares purchased in open market transactions by the plan

administrator will be allocated to a Shareholder based on the average purchase price, excluding any brokerage charges or other

charges, of all shares purchased in the open market.

Equiniti will maintain all Shareholder accounts and furnish written confirmations of all transactions in the accounts,

including information needed by Shareholders for personal and tax records. Equiniti will hold shares in the account of the

Shareholders in non-certificated form in the name of the participant, and each Shareholder's proxy, if any, will include those

shares purchased pursuant to the DRP. Each participant, nevertheless, has the right to request certificates for whole and

fractional shares owned. The Fund will issue certificates in its sole discretion. Equiniti will distribute all proxy solicitation

materials, if any, to participating Shareholders.

In the case of Shareholders, such as banks, brokers or nominees, that hold shares for others who are beneficial owners

participating under the DRP, Equiniti will administer the DRP on the basis of the number of shares certified from time to time

by the record shareholder as representing the total amount of shares registered in the Shareholder's name and held for the

account of beneficial owners participating under the DRP.

Neither Equiniti nor the Fund shall have any responsibility or liability beyond the exercise of ordinary care for any

action taken or omitted pursuant to the DRP, nor shall they have any duties, responsibilities or liabilities except such as

expressly set forth herein. Neither shall they be liable hereunder for any act done in good faith or for any good faith omissions

to act, including, without limitation, failure to terminate a participant's account prior to receipt of written notice of his or her

death or with respect to prices at which shares are purchased or sold for the participant's account and the terms on which such

purchases and sales are made, subject to applicable provisions of the federal securities laws.

The automatic reinvestment of Distributions will not relieve participants of any federal, state or local income tax that

may be payable (or required to be withheld) on such Distributions.

The Fund reserves the right to amend or terminate the DRP upon 60 days' notice to Shareholders. There is no direct

service charge to participants with regard to purchases under the DRP; however, the Fund reserves the right to amend the DRP

to include a service charge payable by the participants.

All correspondence concerning the DRP should be directed to Equiniti at PO Box 500, Newark, NJ 07101. Certain

transactions can be performed by calling the toll free number (866) 277-8243.

**PORTFOLIO PROXY VOTING POLICIES AND PROXY VOTING RECORD (Unaudited)** 

The Fund has delegated its proxy voting responsibility to the Adviser. The proxy voting policies and procedures

of the Adviser are set forth below. The guidelines are reviewed periodically by the Adviser and the Independent Trustees

and, accordingly, are subject to change. Based on the nature of the registrant's investment strategy, the Adviser does not

expect to receive proxy proposals but may from time to time receive amendments, consents or resolutions applicable to

investments held by the Fund.

It is the policy of the Fund to delegate the responsibility for voting proxies relating to portfolio securities held

by the Fund to the Fund's Adviser as a part of the Adviser's general management of the Fund's portfolio, subject to the

continuing oversight of the Board. The Board has delegated such responsibility to the Adviser, and directs the Adviser to

vote proxies relating to portfolio securities held by the Fund consistent with the proxy voting policies and procedures.

The Adviser may retain one or more vendors to review, monitor and recommend how to vote proxies in a manner

consistent with the proxy voting policies and procedures, to ensure that such proxies are voted on a timely basis and to

provide reporting and/or record retention services in connection with proxy voting for the Fund.

The right to vote a proxy with respect to portfolio securities held by the Fund is an asset of the Fund. The

Adviser, to which authority to vote on behalf of the Fund is delegated, acts as a fiduciary of the Fund and must vote

proxies in a manner consistent with the best interest of the Fund and its Shareholders. In discharging this fiduciary duty,

the Adviser must maintain and adhere to its policies and procedures for addressing conflicts of interest and must vote

proxies in a manner substantially consistent with its policies, procedures and guidelines, as presented to the Board.

The Fund shall file an annual report of each proxy voted with respect to portfolio securities of the Fund during

the twelve-month period ended June 30 on Form N-PX not later than August 31 of each year. The Fund's voting record

is available (i) without charge, upon request, by calling the Fund toll-free at (866) 277-8243, (ii) free of charge on our

website (www.carlylecreditincomefund.com), and (iii) in the Form N-PX filing on the SEC's website at www.sec.gov.

The Fund files its complete schedule of portfolio holdings with the SEC for the first quarter and the third quarter

of each fiscal year on Form N-PORT. The Fund's Form N-PORT filings are available on the SEC's website at

www.sec.gov.

**ADDITIONAL INFORMATION**

**CARLYLE CREDIT INCOME FUND**

---

| | |
|:---|:---|
| **Adviser** | Carlyle Global Credit Investment Management L.L.C. |
| **Transfer Agent** | Equiniti Trust Company LLC, (formerly known as American Stock Transfer & Trust <br>Company)<br>|
| **Legal Counsel** | Dechert LLP |
| **Ticker Symbols** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common Shares | CCIF |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred Shares | CCID |

---

© 2026 The Carlyle Group Inc. All rights reserved.

**PRIVACY NOTICE**

As a Carlyle Credit Income Fund shareholder, you are entitled to know how we protect your personal information and how we limit its

disclosure.

**Information Sources**

We obtain non-public personal information about our shareholders from transactions with us, our affiliates, or others.

**Protection of Information**

We do not disclose any non-public personal information (such as names on a customer list) about current or former customers to anyone,

except as permitted by law.

**Disclosure of Information**

We may use details about you and your investments to help us, our financial service affiliates, or firms that jointly market their financial

products and services with ours, to better serve your investment needs or suggest educational material that may be of interest to you. If this

requires us to provide you with an opportunity to "opt in" or "opt out" of such information sharing with a firm not affiliated with us, you will

receive notification on how to do so, before any such sharing takes place.

**Right of Refusal**

We will not disclose your personal information to unaffiliated third parties (except as permitted by law), unless we first offer you a reasonable

opportunity to refuse or "opt out" of such disclosure.

**Other Security Measures**

We maintain physical, electronic and procedural safeguards to protect your personal account information. Our employees and agents have

access to that information only so that they may offer you products or provide services, for example, when responding to your account

questions.

**Who We Are**

This notice describes the privacy policy of the Carlyle Credit Income Fund. In the event it is updated or changed, we will post an updated

notice on our website at www.carlylecreditcncomefund.com. If you have any questions about this privacy policy, write to us at PO Box 500,

Newark, NJ 07101 or call us at (866) 277-8243.

![Carlyle-Logo-blue.jpg](ck0001517767-20260331_g1.jpg)

This report must be preceded or accompanied by a prospectus.

**Visit Us**

carlylecreditcncomefund.com

**Call Us**

(866) 277-8243

The Fund's transfer agent is Equiniti Trust Company, LLC

PO Box 500, Newark, NJ 07101

All rights reserved.

**CCIFSAR 05192026**

**<u>Item 2. Code of Ethics</u>**

Not applicable for semi-annual reports.

**<u>Item 3. Audit Committee Financial Expert</u>**

Not applicable for semi-annual reports.

**<u>Item 4. Principal Accountant Fees and Services</u>**

Not applicable for semi-annual reports.

**<u>Item 5. Audit Committee of Listed Companies</u>**

Not applicable for semi-annual reports.

**<u>Item 6. Schedule of Investments</u>**

(a)The schedule of investments is included as part of the Reports to Shareholders filed under

Item 1(a) of this report.

(b)Not applicable.

**<u>Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies</u>**

Not applicable.

**<u>Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies</u>**

Not applicable.

**<u>Item 9. Proxy Disclosures for Open-End Management Investment Companies</u>**

Not applicable.

**<u>Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies</u>**

Not applicable.

**<u>Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract</u>**

Not applicable.

**<u>Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Funds</u>**

Not applicable for semi-annual reports.

**<u>Item 13. Portfolio Managers of Closed-End Management Investment Companies</u>**

(a)(1)Not applicable for semi-annual reports.

(a)(2)Not applicable for semi-annual reports.

(a)(3)Not applicable for semi-annual reports.

(a)(4)Not applicable for semi-annual reports.

(b)There has been no change, as of the date of this filing, in any of the portfolio managers identified in response to

paragraph (a)(1) of this Item in the registrant's most recently filed annual report on Form N-CSR.

**<u>Item 14. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers</u>**

Not applicable.

**<u>Item 15. Submission of Matters to a Vote of Security Holders</u>**

There were no material changes to the procedures by which the Shareholders may recommend nominees to the Board during

the period covered by the semi-annual report included in Item 1(a) of this Form N-CSR.

**<u>Item 16. Controls and Procedures</u>**

(a)Based on an evaluation of the Registrant's disclosure controls and procedures as of a date within 90 days of the

filing date of this Form N-CSR, the principal executive officer and principal financial officer of the Registrant have

concluded that the disclosure controls and procedures of the Registrant are reasonably designed to ensure that the

information required in filings on Form N-CSR is recorded, processed, summarized, and reported by the filing date,

including that information required to be disclosed is accumulated and communicated to the Registrant's

management, including the Registrant's principal executive officer and principal financial officer, as appropriate to

allow timely decisions regarding required disclosure.

(b)There were no significant changes in the Registrant's internal control over financial reporting that occurred during

the period covered by this report that have materially affected, or are reasonably likely to materially affect, the

Registrant's internal control over financial reporting.

**<u>Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies</u>**

(a)Not applicable.

(b)Not applicable.

**<u>Item 18. Recovery of Erroneously Awarded Compensation</u>**

(a)Not applicable.

(b)Not applicable.

**<u>Item 19. Exhibits</u>**

---

| | |
|:---|:---|
| (a)(1) | Not applicable for semi-annual reports. |
| (a)(2) | Not applicable for semi-annual reports. |
| (a)(3) | <u>[Certifications required by Section 302 of the Sarbanes-Oxley Act of 2002 (and Item 19(a)(3) of Form N-CSR)](ccif_202603xn-csrxexxcert.htm)</u><br><u>[are filed herewith](ccif_202603xn-csrxexxcert.htm)</u><u>[.](ccif_202603xn-csrxexxcert.htm)</u><br>|
| (b) | <u>[Certifications required by Section 906 of the Sarbanes-Oxley Act of 2002 (and Item 19(b) of Form N-CSR) are](ccif_202603xn-csrxexxcert9.htm)</u><br><u>[filed herewith.](ccif_202603xn-csrxexxcert9.htm)</u><br>|

---

## Ex-99

**Exhibit 19(a)(3)**

**CERTIFICATIONS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Nishil Mehta certify that:

1. I have reviewed this report on Form N-CSR of Carlyle Credit Income Fund;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a

material fact necessary to make the statements made, in light of the circumstances under which such statements

were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly

present in all material respects the financial condition, results of operations, changes in net assets, and cash

flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and

for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure

controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal

control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for

the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be

designed under our supervision, to ensure that material information relating to the registrant, including its

consolidated subsidiaries, is made known to us by others within those entities, particularly during the

period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial

reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of

financial reporting and the preparation of financial statements for external purposes in accordance with

generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this

report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within

90 days prior to the filing date of this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred

during the period covered by this report that has materially affected, or is reasonably likely to materially

affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit

committee of the registrant's board of trustees (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over

financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process,

summarize, and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant

role in the registrant's internal control over financial reporting.

<u>/s/ Nishil Mehta</u> 

By: Nishil Mehta

Principal Executive Officer

Date: May 19, 2026

**Exhibit 19(a)(3)**

**CERTIFICATIONS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Nelson Joseph certify that:

1. I have reviewed this report on Form N-CSR of Carlyle Credit Income Fund;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a

material fact necessary to make the statements made, in light of the circumstances under which such statements

were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly

present in all material respects the financial condition, results of operations, changes in net assets, and cash

flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and

for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure

controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal

control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for

the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be

designed under our supervision, to ensure that material information relating to the registrant, including its

consolidated subsidiaries, is made known to us by others within those entities, particularly during the

period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial

reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of

financial reporting and the preparation of financial statements for external purposes in accordance with

generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this

report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within

90 days prior to the filing date of this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred

during the period covered by this report that has materially affected, or is reasonably likely to materially

affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit

committee of the registrant's board of trustees (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over

financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process,

summarize, and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant

role in the registrant's internal control over financial reporting.

<u>/s/ Nelson Joseph</u> 

By: Nelson Joseph

Principal Financial Officer

Date: May 19, 2026

## Ex-99

**Exhibit 19(b)**

**CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

Nishil Mehta, Principal Executive Officer, and Nelson Joseph, Principal Financial Officer, of Carlyle Credit Income

Fund (the "Registrant"), each certify to the best of his or her knowledge that:

1. The Registrant's periodic report on Form N-CSR for the period ended March 31, 2026 (the "Form N-

CSR") fully complies with the requirements of Section 15(d) of the Securities Exchange Act of 1934, as

amended; and

2. The information contained in the Form N-CSR fairly presents, in all material respects, the financial

condition and results of operations of the Registrant. This certification is being furnished to the

Commission solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Form N-CSR filed

with the Commission.

---

| | |
|:---|:---|
| Principal Executive Officer | Principal Financial Officer |
| Carlyle Credit Income Fund | Carlyle Credit Income Fund |
| /s/ Nishil Mehta | /s/ Nelson Joseph |
| Nishil Mehta | Nelson Joseph |
| Date: May 19, 2026 | Date: May 19, 2026 |

---